Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Peter Goadsby, MD, PhD

    Address675 Nelson Rising Lane
    San Francisco CA 94143
    Phone415-353-8393

       ORNG Applications 
       Websites
       In The News
       Global Health
       More Info

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Tso AR, Goadsby PJ. New targets for migraine therapy. Curr Treat Options Neurol. 2014 Nov; 16(11):318.
        View in: PubMed
      2. Dodick DW, Goadsby PJ, Silberstein SD, Lipton RB, Olesen J, Ashina M, Wilks K, Kudrow D, Kroll R, Kohrman B, Bargar R, Hirman J, Smith J. Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial. Lancet Neurol. 2014 Nov; 13(11):1100-7.
        View in: PubMed
      3. Goadsby PJ. Hemicrania continua- Major Shortcomings in the new classification or rigid thinking is death to progress. J Headache Pain. 2014; 15(1):53.
        View in: PubMed
      4. Dodick DW, Goadsby PJ, Spierings EL, Scherer JC, Sweeney SP, Grayzel DS. Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study. Lancet Neurol. 2014 Sep; 13(9):885-92.
        View in: PubMed
      5. Dodick DW, Goadsby PJ, Spierings EL, Scherer JC, Sweeney SP, Grayzel DS. Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study. Lancet Neurol. 2014 Sep; 13(9):885-92.
        View in: PubMed
      6. Ho TW, Connor KM, Zhang Y, Pearlman E, Koppenhaver J, Fan X, Lines C, Edvinsson L, Goadsby PJ, Michelson D. Randomized controlled trial of the CGRP receptor antagonist telcagepant for migraine prevention. Neurology. 2014 Sep 9; 83(11):958-66.
        View in: PubMed
      7. Martin PR, Reece J, Callan M, MacLeod C, Kaur A, Gregg K, Goadsby PJ. Behavioral management of the triggers of recurrent headache: A randomized controlled trial. Behav Res Ther. 2014 Oct; 61:1-11.
        View in: PubMed
      8. Gelfand AA, Goadsby PJ. Medication overuse in children and adolescents. Curr Pain Headache Rep. 2014 Jul; 18(7):428.
        View in: PubMed
      9. Viana M, Sainaghi PP, Stecco A, Mortara F, Sprenger T, Goadsby PJ. Headache in a patient with crowned dens: report of a new case. Headache. 2014 Jul; 54(7):1211-6.
        View in: PubMed
      10. Goadsby PJ. Correction: Hemicrania continua- building on experience and clinical science. J Headache Pain. 2014; 15:29.
        View in: PubMed
      11. Al-Hashel JY, Ahmed SF, Alroughani R, Goadsby PJ. Migraine among medical students in Kuwait University. J Headache Pain. 2014; 15:26.
        View in: PubMed
      12. Schankin CJ, Maniyar FH, Sprenger T, Chou DE, Eller M, Goadsby PJ. The relation between migraine, typical migraine aura and "visual snow". Headache. 2014 Jun; 54(6):957-66.
        View in: PubMed
      13. Maniyar FH, Sprenger T, Schankin C, Goadsby PJ. Photic hypersensitivity in the premonitory phase of migraine - a positron emission tomography study. Eur J Neurol. 2014 Sep; 21(9):1178-83.
        View in: PubMed
      14. Goadsby PJ. Stress and migraine: Something expected, something unexpected. Neurology. 2014 Apr 22; 82(16):1388-9.
        View in: PubMed
      15. Schankin CJ, Maniyar FH, Digre KB, Goadsby PJ. 'Visual snow' - a disorder distinct from persistent migraine aura. Brain. 2014 May; 137(Pt 5):1419-28.
        View in: PubMed
      16. Goadsby PJ. Migraine-like features in cluster headache. Headache. 2014 Mar; 54(3):555.
        View in: PubMed
      17. Hoffmann J, Akerman S, Goadsby PJ. Efficacy and mechanism of anticonvulsant drugs in migraine. Expert Rev Clin Pharmacol. 2014 Mar; 7(2):191-201.
        View in: PubMed
      18. Hoffmann J, Goadsby PJ. Emerging targets in migraine. CNS Drugs. 2014 Jan; 28(1):11-7.
        View in: PubMed
      19. Park J, Moon H, Akerman S, Holland PR, Lasalandra MP, Andreou AP, Ferrari MD, van den Maagdenberg AM, Goadsby PJ. Differential trigeminovascular nociceptive responses in the thalamus in the familial hemiplegic migraine 1 knock-in mouse: A Fos protein study. Neurobiol Dis. 2014 Apr; 64:1-7.
        View in: PubMed
      20. Al-Hashel JY, Ahmed SF, Alroughani R, Goadsby PJ. Migraine misdiagnosis as a sinusitis, a delay that can last for many years. J Headache Pain. 2013; 14(1):97.
        View in: PubMed
      21. Maniyar FH, Sprenger T, Monteith T, Schankin C, Goadsby PJ. Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain. 2014 Jan; 137(Pt 1):232-41.
        View in: PubMed
      22. Gelfand AA, Reider AC, Goadsby PJ. Outcomes of greater occipital nerve injections in pediatric patients with chronic primary headache disorders. Pediatr Neurol. 2014 Feb; 50(2):135-9.
        View in: PubMed
      23. Thorlund K, Mills EJ, Wu P, Ramos E, Chatterjee A, Druyts E, Goadsby PJ. Comparative efficacy of triptans for the abortive treatment of migraine: A multiple treatment comparison meta-analysis. Cephalalgia. 2014 Apr; 34(4):258-67.
        View in: PubMed
      24. Akerman S, Holland PR, Lasalandra MP, Goadsby PJ. Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and "triptan" receptors: implications in migraine. J Neurosci. 2013 Sep 11; 33(37):14869-77.
        View in: PubMed
      25. Marcus R, Goadsby PJ, Dodick D, Stock D, Manos G, Fischer TZ. BMS-927711 for the acute treatment of migraine: A double-blind, randomized, placebo controlled, dose-ranging trial. Cephalalgia. 2014 Feb; 34(2):114-25.
        View in: PubMed
      26. Simpson JC, Goadsby PJ, Prabhakar P. Positive persistent visual symptoms (visual snow) presenting as a migraine variant in a 12-year-old girl. Pediatr Neurol. 2013 Nov; 49(5):361-3.
        View in: PubMed
      27. Royce JS, Goadsby PJ. Migraine with cranial autonomic features following surgically induced post-ganglionic sympathetic lesion. Acta Neurol Scand. 2014 Feb; 129(2):e6-8.
        View in: PubMed
      28. Goadsby PJ. Author's reply on Pathophysiology of migraine. Ann Indian Acad Neurol. 2013 Jul; 16(3):456-7.
        View in: PubMed
      29. Goadsby PJ. The last two years. Cephalalgia. 2013 Jul; 33(10):811-2.
        View in: PubMed
      30. Sanderson JC, Devine EB, Lipton RB, Bloudek LM, Varon SF, Blumenfeld AM, Goadsby PJ, Buse DC, Sullivan SD. Headache-related health resource utilisation in chronic and episodic migraine across six countries. J Neurol Neurosurg Psychiatry. 2013 Dec; 84(12):1309-17.
        View in: PubMed
      31. Gelfand AA, Reider AC, Goadsby PJ. Cranial autonomic symptoms in pediatric migraine are the rule, not the exception. Neurology. 2013 Jul 30; 81(5):431-6.
        View in: PubMed
      32. Hoffmann J, Goadsby PJ. Update on intracranial hypertension and hypotension. Curr Opin Neurol. 2013 Jun; 26(3):240-7.
        View in: PubMed
      33. Wilbrink LA, Teernstra OP, Haan J, van Zwet EW, Evers SM, Spincemaille GH, Veltink PH, Mulleners W, Brand R, Huygen FJ, Jensen RH, Paemeleire K, Goadsby PJ, Visser-Vandewalle V, Ferrari MD. Occipital nerve stimulation in medically intractable, chronic cluster headache. The ICON study: rationale and protocol of a randomised trial. Cephalalgia. 2013 Nov; 33(15):1238-47.
        View in: PubMed
      34. Sprenger T, Supronsinchai W, Goadsby PJ. New onset migraine with aura after treatment initiation with ivabradine. J Headache Pain. 2013; 14(1):45.
        View in: PubMed
      35. Sprenger T, Supronsinchai W, Goadsby PJ. New onset migraine with aura after treatment initiation with ivabradine. J Headache Pain. 2013; 14(1):45.
        View in: PubMed
      36. Maniyar FH, Goadsby PJ. Functional imaging in chronic migraine. Curr Pain Headache Rep. 2013 May; 17(5):333.
        View in: PubMed
      37. Goadsby PJ. All that is obvious is not clear: what is the origin of throbbing pain in migraine? Pain. 2013 Jul; 154(7):970-1.
        View in: PubMed
      38. Goadsby PJ. Sphenopalatine (pterygopalatine) ganglion stimulation and cluster headache: new hope for ye who enter here. Cephalalgia. 2013 Jul; 33(10):813-5.
        View in: PubMed
      39. Viana M, Genazzani AA, Terrazzino S, Nappi G, Goadsby PJ. Triptan nonresponders: do they exist and who are they? Cephalalgia. 2013 Aug; 33(11):891-6.
        View in: PubMed
      40. Viana M, Sprenger T, Andelova M, Goadsby PJ. The typical duration of migraine aura: a systematic review. Cephalalgia. 2013 May; 33(7):483-90.
        View in: PubMed
      41. Gantenbein AR, Sandor PS, Fritschy J, Turner R, Goadsby PJ, Kaube H. Sensory information processing may be neuroenergetically more demanding in migraine patients. Neuroreport. 2013 Mar 6; 24(4):202-5.
        View in: PubMed
      42. Eller M, Goadsby PJ. MRI in headache. Expert Rev Neurother. 2013 Mar; 13(3):263-73.
        View in: PubMed
      43. Asano E, Goadsby PJ. How do we fashion better trials for neurostimulator studies in migraine? Neurology. 2013 Feb 19; 80(8):694.
        View in: PubMed
      44. Afridi SK, Giffin NJ, Kaube H, Goadsby PJ. A randomized controlled trial of intranasal ketamine in migraine with prolonged aura. Neurology. 2013 Feb 12; 80(7):642-7.
        View in: PubMed
      45. Goadsby PJ, Silberstein SD. Migraine triggers: harnessing the messages of clinical practice. Neurology. 2013 Jan 29; 80(5):424-5.
        View in: PubMed
      46. Storer RJ, Goadsby PJ. Topiramate is likely to act outside of the trigeminocervical complex. Cephalalgia. 2013 Apr; 33(5):291-300.
        View in: PubMed
      47. Goadsby PJ. Autonomic nervous system control of the cerebral circulation. Handb Clin Neurol. 2013; 117:193-201.
        View in: PubMed
      48. Goadsby PJ. Analysis of occipital nerve stimulation in studies of chronic migraine and broader implications of social media in clinical trials. Cephalalgia. 2013 Feb; 33(3):214-5.
        View in: PubMed
      49. Hansen JM, Lipton RB, Dodick DW, Silberstein SD, Saper JR, Aurora SK, Goadsby PJ, Charles A. Migraine headache is present in the aura phase: a prospective study. Neurology. 2012 Nov 13; 79(20):2044-9.
        View in: PubMed
      50. Akerman S, Holland PR, Summ O, Lasalandra MP, Goadsby PJ. A translational in vivo model of trigeminal autonomic cephalalgias: therapeutic characterization. Brain. 2012 Dec; 135(Pt 12):3664-75.
        View in: PubMed
      51. Holland PR, Akerman S, Andreou AP, Karsan N, Wemmie JA, Goadsby PJ. Acid-sensing ion channel 1: a novel therapeutic target for migraine with aura. Ann Neurol. 2012 Oct; 72(4):559-63.
        View in: PubMed
      52. Gelfand AA, Goadsby PJ. Treatment of pediatric migraine in the emergency room. Pediatr Neurol. 2012 Oct; 47(4):233-41.
        View in: PubMed
      53. Gelfand AA, Thomas KC, Goadsby PJ. Before the headache: infant colic as an early life expression of migraine. Neurology. 2012 Sep 25; 79(13):1392-6.
        View in: PubMed
      54. Hoffmann J, Supronsinchai W, Andreou AP, Summ O, Akerman S, Goadsby PJ. Olvanil acts on transient receptor potential vanilloid channel 1 and cannabinoid receptors to modulate neuronal transmission in the trigeminovascular system. Pain. 2012 Nov; 153(11):2226-32.
        View in: PubMed
      55. Goadsby PJ. Pathophysiology of migraine. Ann Indian Acad Neurol. 2012 Aug; 15(Suppl 1):S15-22.
        View in: PubMed
      56. Goadsby PJ. Trigeminal autonomic cephalalgias. Continuum (Minneap Minn). 2012 Aug; 18(4):883-95.
        View in: PubMed
      57. Gelfand AA, Goadsby PJ. Primary sex headache in adolescents. Pediatrics. 2012 Aug; 130(2):e439-41.
        View in: PubMed
      58. Sprenger T, Seifert CL, Valet M, Andreou AP, Foerschler A, Zimmer C, Collins DL, Goadsby PJ, Tölle TR, Chakravarty MM. Assessing the risk of central post-stroke pain of thalamic origin by lesion mapping. Brain. 2012 Aug; 135(Pt 8):2536-45.
        View in: PubMed
      59. Bloudek LM, Stokes M, Buse DC, Wilcox TK, Lipton RB, Goadsby PJ, Varon SF, Blumenfeld AM, Katsarava Z, Pascual J, Lanteri-Minet M, Cortelli P, Martelletti P. Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS). J Headache Pain. 2012 Jul; 13(5):361-78.
        View in: PubMed
      60. Nesbitt AD, Goadsby PJ. Authors' reply to Litwin and Malhotra. BMJ. 2012; 344:e3551.
        View in: PubMed
      61. Maniyar FH, Starr P, Goadsby PJ. Paroxysmal sneezing after hypothalamic deep brain stimulation for cluster headache. Cephalalgia. 2012 Jun; 32(8):641-4.
        View in: PubMed
      62. Nesbitt AD, Goadsby PJ. Cluster headache. BMJ. 2012; 344:e2407.
        View in: PubMed
      63. Viana M, Mathias CJ, Goadsby PJ. Headache in three new cases of Harlequin syndrome with accompanying pharmacological comparison with migraine. J Neurol Neurosurg Psychiatry. 2012 Jun; 83(6):663-5.
        View in: PubMed
      64. Diener HC, Dodick DW, Goadsby PJ, Lipton RB, Olesen J, Silberstein SD. Chronic migraine--classification, characteristics and treatment. Nat Rev Neurol. 2011; 8(3):162-71.
        View in: PubMed
      65. Goadsby PJ. Herbalism helps headache. Brain. 2012 Feb; 135(Pt 2):318-9.
        View in: PubMed
      66. Hoffmann J, Goadsby PJ. New Agents for Acute Treatment of Migraine: CGRP Receptor Antagonists, iNOS Inhibitors. Curr Treat Options Neurol. 2012 Feb; 14(1):50-9.
        View in: PubMed
      67. Peer Mohamed B, Goadsby PJ, Prabhakar P. Safety and efficacy of flunarizine in childhood migraine: 11 years' experience, with emphasis on its effect in hemiplegic migraine. Dev Med Child Neurol. 2012 Mar; 54(3):274-7.
        View in: PubMed
      68. Gelfand AA, Gelfand JM, Prabakhar P, Goadsby PJ. Ophthalmoplegic "migraine" or recurrent ophthalmoplegic cranial neuropathy: new cases and a systematic review. J Child Neurol. 2012 Jun; 27(6):759-66.
        View in: PubMed
      69. Goadsby PJ, Akerman S. The trigeminovascular system does not require a peripheral sensory input to be activated--migraine is a central disorder. Focus on 'Effect of cortical spreading depression on basal and evoked traffic in the trigeminovascular sensory system'. Cephalalgia. 2012 Jan; 32(1):3-5.
        View in: PubMed
      70. Nagy AJ, Gandhi S, Bhola R, Goadsby PJ. Intravenous dihydroergotamine for inpatient management of refractory primary headaches. Neurology. 2011 Nov 15; 77(20):1827-32.
        View in: PubMed
      71. Tepper SJ, Kori SH, Goadsby PJ, Winner PK, Wang MH, Silberstein SD, Cutrer FM. MAP0004, orally inhaled dihydroergotamine for acute treatment of migraine: efficacy of early and late treatments. Mayo Clin Proc. 2011 Oct; 86(10):948-55.
        View in: PubMed
      72. Akerman S, Holland PR, Goadsby PJ. Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci. 2011 Oct; 12(10):570-84.
        View in: PubMed
      73. Andreou AP, Goadsby PJ. Topiramate in the treatment of migraine: a kainate (glutamate) receptor antagonist within the trigeminothalamic pathway. Cephalalgia. 2011 Oct; 31(13):1343-58.
        View in: PubMed
      74. Mathew R, Andreou AP, Chami L, Bergerot A, van den Maagdenberg AM, Ferrari MD, Goadsby PJ. Immunohistochemical characterization of calcitonin gene-related peptide in the trigeminal system of the familial hemiplegic migraine 1 knock-in mouse. Cephalalgia. 2011 Oct; 31(13):1368-80.
        View in: PubMed
      75. Knash ME, Goadsby PJ. Migraine misdiagnosed as idiopathic intracranial hypertension. Headache. 2011 Nov-Dec; 51(10):1537-9.
        View in: PubMed
      76. Charbit AR, Akerman S, Goadsby PJ. Trigeminocervical complex responses after lesioning dopaminergic A11 nucleus are modified by dopamine and serotonin mechanisms. Pain. 2011 Oct; 152(10):2365-76.
        View in: PubMed
      77. Díaz-Insa S, Goadsby PJ, Zanchin G, Fortea J, Falqués M, Vila C. The impact of allodynia on the efficacy of almotriptan when given early in migraine: data from the "Act when mild" study. Int J Neurosci. 2011 Dec; 121(12):655-61.
        View in: PubMed
      78. Viana M, Glastonbury CM, Sprenger T, Goadsby PJ. Trigeminal neuropathic pain in a patient with progressive facial hemiatrophy (parry-romberg syndrome). Arch Neurol. 2011 Jul; 68(7):938-43.
        View in: PubMed
      79. Stokes M, Becker WJ, Lipton RB, Sullivan SD, Wilcox TK, Wells L, Manack A, Proskorovsky I, Gladstone J, Buse DC, Varon SF, Goadsby PJ, Blumenfeld AM. Cost of health care among patients with chronic and episodic migraine in Canada and the USA: results from the International Burden of Migraine Study (IBMS). Headache. 2011 Jul-Aug; 51(7):1058-77.
        View in: PubMed
      80. Payne KA, Varon SF, Kawata AK, Yeomans K, Wilcox TK, Manack A, Buse DC, Lipton RB, Goadsby PJ, Blumenfeld AM. The International Burden of Migraine Study (IBMS): study design, methodology, and baseline cohort characteristics. Cephalalgia. 2011 Jul; 31(10):1116-30.
        View in: PubMed
      81. Schievink WI, Dodick DW, Mokri B, Silberstein S, Bousser MG, Goadsby PJ. Diagnostic criteria for headache due to spontaneous intracranial hypotension: a perspective. Headache. 2011 Oct; 51(9):1442-4.
        View in: PubMed
      82. Mitsikostas DD, Knight YE, Lasalandra M, Kavantzas N, Goadsby PJ. Triptans attenuate capsaicin-induced CREB phosphorylation within the trigeminal nucleus caudalis: a mechanism to prevent central sensitization? J Headache Pain. 2011 Aug; 12(4):411-7.
        View in: PubMed
      83. Goadsby PJ. New daily persistent headache: a syndrome, not a discrete disorder. Headache. 2011 Apr; 51(4):650-3.
        View in: PubMed
      84. Evers S, Goadsby P, Jensen R, May A, Pascual J, Sixt G. Treatment of miscellaneous idiopathic headache disorders (Group 4 of the IHS classification)--report of an EFNS task force. Eur J Neurol. 2011 Jun; 18(6):803-12.
        View in: PubMed
      85. Bartsch T, Goadsby PJ. Central mechanisms of peripheral nerve stimulation in headache disorders. Prog Neurol Surg. 2011; 24:16-26.
        View in: PubMed
      86. Hewitt DJ, Aurora SK, Dodick DW, Goadsby PJ, Ge YJ, Bachman R, Taraborelli D, Fan X, Assaid C, Lines C, Ho TW. Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine. Cephalalgia. 2011 Apr; 31(6):712-22.
        View in: PubMed
      87. Maniyar FH, Goadsby PJ. Brain hemorrhage: clinical high-risk factors for subarachnoid hemorrhage. Nat Rev Neurol. 2011 Mar; 7(3):134-5.
        View in: PubMed
      88. Monteith TS, Goadsby PJ. Acute migraine therapy: new drugs and new approaches. Curr Treat Options Neurol. 2011 Feb; 13(1):1-14.
        View in: PubMed
      89. Cittadini E, Goadsby PJ. Update on hemicrania continua. Curr Pain Headache Rep. 2011 Feb; 15(1):51-6.
        View in: PubMed
      90. von Brevern M, Baloh RW, Bisdorff A, Brandt T, Bronstein AM, Furman JM, Goadsby PJ, Neuhauser H, Radtke A, Versino M. Response to: Migraine and vertigo: a marriage of convenience? Headache. 2011 Feb; 51(2):308-9.
        View in: PubMed
      91. Summ O, Andreou AP, Akerman S, Goadsby PJ. A potential nitrergic mechanism of action for indomethacin, but not of other COX inhibitors: relevance to indomethacin-sensitive headaches. J Headache Pain. 2010 Dec; 11(6):477-83.
        View in: PubMed
      92. Goadsby PJ. Calcitonin gene-related peptide receptor antagonists and triptans: a tale of two treatments. Neurology. 2010 Oct 26; 75(17):1494-5.
        View in: PubMed
      93. Saper JR, Dodick DW, Silberstein SD, McCarville S, Sun M, Goadsby PJ. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia. 2011 Feb; 31(3):271-85.
        View in: PubMed
      94. Weatherall MW, Telzerow AJ, Cittadini E, Kaube H, Goadsby PJ. Intravenous aspirin (lysine acetylsalicylate) in the inpatient management of headache. Neurology. 2010 Sep 21; 75(12):1098-103.
        View in: PubMed
      95. Classey JD, Bartsch T, Goadsby PJ. Distribution of 5-HT(1B), 5-HT(1D) and 5-HT(1F) receptor expression in rat trigeminal and dorsal root ganglia neurons: relevance to the selective anti-migraine effect of triptans. Brain Res. 2010 Nov 18; 1361:76-85.
        View in: PubMed
      96. Ho TW, Edvinsson L, Goadsby PJ. CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol. 2010 Oct; 6(10):573-82.
        View in: PubMed
      97. Blumenfeld AM, Varon SF, Wilcox TK, Buse DC, Kawata AK, Manack A, Goadsby PJ, Lipton RB. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia. 2011 Feb; 31(3):301-15.
        View in: PubMed
      98. Bhola R, Goadsby PJ. A trans-cultural comparison of the organisation of care at headache centres world-wide. Cephalalgia. 2011 Feb; 31(3):316-30.
        View in: PubMed
      99. Summ O, Charbit AR, Andreou AP, Goadsby PJ. Modulation of nocioceptive transmission with calcitonin gene-related peptide receptor antagonists in the thalamus. Brain. 2010 Sep; 133(9):2540-8.
        View in: PubMed
      100. Gelfand AA, Fullerton HJ, Goadsby PJ. Child neurology: Migraine with aura in children. Neurology. 2010 Aug 3; 75(5):e16-9.
        View in: PubMed
      101. Cittadini E, Goadsby PJ. Retraction. Psychiatric side effects during methysergide treatment. J Neurol Neurosurg Psychiatry. 2010 Aug; 81(8):942.
        View in: PubMed
      102. Kernick DP, Goadsby PJ. Guidance for the management of headache in sport on behalf of The Royal College of General Practitioners and The British Association for the Study of Headache. Cephalalgia. 2011 Jan; 31(1):106-11.
        View in: PubMed
      103. Akerman S, Holland PR, Lasalandra MP, Goadsby PJ. Inhibition of trigeminovascular dural nociceptive afferents by Ca(2+)-activated K(+) (MaxiK/BK(Ca)) channel opening. Pain. 2010 Oct; 151(1):128-36.
        View in: PubMed
      104. Summ O, Holland PR, Akerman S, Goadsby PJ. TRPV1 receptor blockade is ineffective in different in vivo models of migraine. Cephalalgia. 2011 Jan; 31(2):172-80.
        View in: PubMed
      105. Cittadini E, Goadsby PJ. Hemicrania continua: a clinical study of 39 patients with diagnostic implications. Brain. 2010 Jul; 133(Pt 7):1973-86.
        View in: PubMed
      106. Charbit AR, Akerman S, Goadsby PJ. Dopamine: what's new in migraine? Curr Opin Neurol. 2010 Jun; 23(3):275-81.
        View in: PubMed
      107. Edvinsson L, Ekman R, Goadsby PJ. Measurement of vasoactive neuropeptides in biological materials: problems and pitfalls from 30 years of experience and novel future approaches. Cephalalgia. 2010 Jun; 30(6):761-6.
        View in: PubMed
      108. Holland PR, Akerman S, Goadsby PJ. Cortical spreading depression-associated cerebral blood flow changes induced by mechanical stimulation are modulated by AMPA and GABA receptors. Cephalalgia. 2010 May; 30(5):519-27.
        View in: PubMed
      109. Marin JC, Goadsby PJ. Glutamatergic fine tuning with ADX-10059: a novel therapeutic approach for migraine? Expert Opin Investig Drugs. 2010 Apr; 19(4):555-61.
        View in: PubMed
      110. Paemeleire K, Van Buyten JP, Van Buynder M, Alicino D, Van Maele G, Smet I, Goadsby PJ. Phenotype of patients responsive to occipital nerve stimulation for refractory head pain. Cephalalgia. 2010 Jun; 30(6):662-73.
        View in: PubMed
      111. Goadsby PJ, Cittadini E, Cohen AS. Trigeminal autonomic cephalalgias: paroxysmal hemicrania, SUNCT/SUNA, and hemicrania continua. Semin Neurol. 2010 Apr; 30(2):186-91.
        View in: PubMed
      112. Sprenger T, Goadsby PJ. What has functional neuroimaging done for primary headache ... and for the clinical neurologist? J Clin Neurosci. 2010 May; 17(5):547-53.
        View in: PubMed
      113. Lipton RB, Dodick DW, Silberstein SD, Saper JR, Aurora SK, Pearlman SH, Fischell RE, Ruppel PL, Goadsby PJ. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol. 2010 Apr; 9(4):373-80.
        View in: PubMed
      114. Recober A, Goadsby PJ. Calcitonin gene-related peptide: A molecular link between obesity and migraine? Drug News Perspect. 2010 Mar; 23(2):112-7.
        View in: PubMed
      115. Schwedt TJ, Goadsby PJ. 14th International Headache Congress: basic science highlights. Headache. 2010 Mar; 50(3):520-6.
        View in: PubMed
      116. Goadsby PJ, Sprenger T. Current practice and future directions in the prevention and acute management of migraine. Lancet Neurol. 2010 Mar; 9(3):285-98.
        View in: PubMed
      117. Andreou AP, Summ O, Charbit AR, Romero-Reyes M, Goadsby PJ. Animal models of headache: from bedside to bench and back to bedside. Expert Rev Neurother. 2010 Mar; 10(3):389-411.
        View in: PubMed
      118. Cohen AS, Burns B, Goadsby PJ. High-flow oxygen for treatment of cluster headache: a randomized trial. JAMA. 2009 Dec 9; 302(22):2451-7.
        View in: PubMed
      119. Storer RJ, Immke DC, Goadsby PJ. Large conductance calcium-activated potassium channels (BKCa) modulate trigeminovascular nociceptive transmission. Cephalalgia. 2009 Dec; 29(12):1242-58.
        View in: PubMed
      120. Goadsby PJ. "Increasing our understanding of migraine to enhance treatment outcomes"--symposium. Foreword. Cephalalgia. 2009 Dec; 29 Suppl 3:v-vi.
        View in: PubMed
      121. Holland P, Goadsby P, Dodick D, Valade D. Question & answer session. Cephalalgia. 2009 Dec; 29 Suppl 3:22-4.
        View in: PubMed
      122. Sprenger T, Goadsby PJ. Migraine pathogenesis and state of pharmacological treatment options. BMC Med. 2009; 7:71.
        View in: PubMed
      123. Andreou AP, Shields KG, Goadsby PJ. GABA and valproate modulate trigeminovascular nociceptive transmission in the thalamus. Neurobiol Dis. 2010 Feb; 37(2):314-23.
        View in: PubMed
      124. Charbit AR, Akerman S, Holland PR, Goadsby PJ. Neurons of the dopaminergic/calcitonin gene-related peptide A11 cell group modulate neuronal firing in the trigeminocervical complex: an electrophysiological and immunohistochemical study. J Neurosci. 2009 Oct 7; 29(40):12532-41.
        View in: PubMed
      125. Goadsby PJ. Cervicogenic headache: a pain in the neck for some neurologists? Lancet Neurol. 2009 Oct; 8(10):875-7.
        View in: PubMed
      126. Hedlund C, Rapoport AM, Dodick DW, Goadsby PJ. Zolmitriptan nasal spray in the acute treatment of cluster headache: a meta-analysis of two studies. Headache. 2009 Oct; 49(9):1315-23.
        View in: PubMed
      127. Goadsby PJ. Lacrimation, conjunctival injection, nasal symptoms... cluster headache, migraine and cranial autonomic symptoms in primary headache disorders -- what's new? J Neurol Neurosurg Psychiatry. 2009 Oct; 80(10):1057-8.
        View in: PubMed
      128. Obermann M, Nebel K, Schumann C, Holle D, Gizewski ER, Maschke M, Goadsby PJ, Diener HC, Katsarava Z. Gray matter changes related to chronic posttraumatic headache. Neurology. 2009 Sep 22; 73(12):978-83.
        View in: PubMed
      129. Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A, Sándor PS. EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force. Eur J Neurol. 2009 Sep; 16(9):968-81.
        View in: PubMed
      130. Akerman S, Holland PR, Lasalandra MP, Goadsby PJ. Oxygen inhibits neuronal activation in the trigeminocervical complex after stimulation of trigeminal autonomic reflex, but not during direct dural activation of trigeminal afferents. Headache. 2009 Sep; 49(8):1131-43.
        View in: PubMed
      131. Olesen J, Steiner T, Bousser MG, Diener HC, Dodick D, First MB, Goadsby PJ, Göbel H, Lainez MJ, Lipton RB, Nappi G, Sakai F, Schoenen J, Silberstein SD. Proposals for new standardized general diagnostic criteria for the secondary headaches. Cephalalgia. 2009 Dec; 29(12):1331-6.
        View in: PubMed
      132. Charbit AR, Akerman S, Goadsby PJ. Comparison of the effects of central and peripheral dopamine receptor activation on evoked firing in the trigeminocervical complex. J Pharmacol Exp Ther. 2009 Nov; 331(2):752-63.
        View in: PubMed
      133. Cohen AS, Goadsby PJ. Paroxysmal hemicrania responding to topiramate. BMJ Case Rep. 2009; 2009.
        View in: PubMed
      134. Andreou AP, Goadsby PJ. Therapeutic potential of novel glutamate receptor antagonists in migraine. Expert Opin Investig Drugs. 2009 Jun; 18(6):789-803.
        View in: PubMed
      135. Bartsch T, Paemeleire K, Goadsby PJ. Neurostimulation approaches to primary headache disorders. Curr Opin Neurol. 2009 Jun; 22(3):262-8.
        View in: PubMed
      136. Goadsby PJ. Pathophysiology of migraine. Neurol Clin. 2009 May; 27(2):335-60.
        View in: PubMed
      137. Diener HC, Dodick DW, Goadsby PJ, Bigal ME, Bussone G, Silberstein SD, Mathew N, Ascher S, Morein J, Hulihan JF, Biondi DM, Greenberg SJ. Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia. 2009 Oct; 29(10):1021-7.
        View in: PubMed
      138. Holland PR, Goadsby PJ. Cluster headache, hypothalamus, and orexin. Curr Pain Headache Rep. 2009 Apr; 13(2):147-54.
        View in: PubMed
      139. Andreou AP, Holland PR, Goadsby PJ. Activation of iGluR5 kainate receptors inhibits neurogenic dural vasodilatation in an animal model of trigeminovascular activation. Br J Pharmacol. 2009 Jun; 157(3):464-73.
        View in: PubMed
      140. Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR. Neurobiology of migraine. Neuroscience. 2009 Jun 30; 161(2):327-41.
        View in: PubMed
      141. Schulman EA, Peterlin BL, Lake AE, Lipton RB, Hanlon A, Siegel S, Levin M, Goadsby PJ, Markley HG. Defining refractory migraine: results of the RHSIS Survey of American Headache Society members. Headache. 2009 Apr; 49(4):509-18.
        View in: PubMed
      142. Gil-Gouveia R, Goadsby PJ. Neuropsychiatric side-effects of lidocaine: examples from the treatment of headache and a review. Cephalalgia. 2009 May; 29(5):496-508.
        View in: PubMed
      143. Healy DG, Goadsby PJ, Kitchen ND, Yousry T, Hanna MG. Spontaneous intracranial hypotension, hygromata and haematomata. BMJ Case Rep. 2009; 2009:bcr2007132019.
        View in: PubMed
      144. Goadsby PJ, Ferrari MD, Csanyi A, Olesen J, Mills JG. Randomized, double-blind, placebo-controlled, proof-of-concept study of the cortical spreading depression inhibiting agent tonabersat in migraine prophylaxis. Cephalalgia. 2009 Jul; 29(7):742-50.
        View in: PubMed
      145. Bigal ME, Ferrari M, Silberstein SD, Lipton RB, Goadsby PJ. Migraine in the triptan era: lessons from epidemiology, pathophysiology, and clinical science. Headache. 2009 Feb; 49 Suppl 1:S21-33.
        View in: PubMed
      146. Burns B, Watkins L, Goadsby PJ. Treatment of intractable chronic cluster headache by occipital nerve stimulation in 14 patients. Neurology. 2009 Jan 27; 72(4):341-5.
        View in: PubMed
      147. Goadsby PJ. The vascular theory of migraine--a great story wrecked by the facts. Brain. 2009 Jan; 132(Pt 1):6-7.
        View in: PubMed
      148. Kernick DP, Ahmed F, Bahra A, Dowson A, Elrington G, Fontebasso M, Giffin NJ, Lipscombe S, MacGregor A, Peatfield R, Weatherby S, Whitmarsh T, Goadsby PJ. Imaging patients with suspected brain tumour: guidance for primary care. Br J Gen Pract. 2008 Dec; 58(557):880-5.
        View in: PubMed
      149. Burns B, Watkins L, Goadsby PJ. Treatment of hemicrania continua by occipital nerve stimulation with a bion device: long-term follow-up of a crossover study. Lancet Neurol. 2008 Nov; 7(11):1001-12.
        View in: PubMed
      150. Goadsby PJ, Hargreaves R. Refractory migraine and chronic migraine: pathophysiological mechanisms. Headache. 2008 Oct; 48(9):1399-405.
        View in: PubMed
      151. Kernick D, Stapley S, Goadsby PJ, Hamilton W. What happens to new-onset headache presented to primary care? A case-cohort study using electronic primary care records. Cephalalgia. 2008 Nov; 28(11):1188-95.
        View in: PubMed
      152. Goadsby PJ. The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine. Cephalalgia. 2008 Sep; 28 Suppl 2:36-41.
        View in: PubMed
      153. Akerman S, Holland PR, Goadsby PJ. Mechanically-induced cortical spreading depression associated regional cerebral blood flow changes are blocked by Na+ ion channel blockade. Brain Res. 2008 Sep 10; 1229:27-36.
        View in: PubMed
      154. Goadsby PJ, Bartsch T. On the functional neuroanatomy of neck pain. Cephalalgia. 2008 Jul; 28 Suppl 1:1-7.
        View in: PubMed
      155. Silberstein S, Diener HC, Lipton R, Goadsby P, Dodick D, Bussone G, Freitag F, Schwalen S, Ascher S, Morein J, Greenberg S, Biondi D, Hulihan J. Epidemiology, risk factors, and treatment of chronic migraine: a focus on topiramate. Headache. 2008 Jul; 48(7):1087-95.
        View in: PubMed
      156. Goadsby PJ, Goldberg J, Silberstein SD. Migraine in pregnancy. BMJ. 2008 Jun 28; 336(7659):1502-4.
        View in: PubMed
      157. Graves TD, Imbrici P, Kors EE, Terwindt GM, Eunson LH, Frants RR, Haan J, Ferrari MD, Goadsby PJ, Hanna MG, van den Maagdenberg AM, Kullmann DM. Premature stop codons in a facilitating EF-hand splice variant of CaV2.1 cause episodic ataxia type 2. Neurobiol Dis. 2008 Oct; 32(1):10-5.
        View in: PubMed
      158. Goadsby PJ, Hargreaves R. Refractory migraine and chronic migraine: pathophysiological mechanisms. Headache. 2008 Jun; 48(6):799-804.
        View in: PubMed
      159. Goadsby PJ, Cittadini E, Burns B, Cohen AS. Trigeminal autonomic cephalalgias: diagnostic and therapeutic developments. Curr Opin Neurol. 2008 Jun; 21(3):323-30.
        View in: PubMed
      160. Schulman EA, Lake AE, Goadsby PJ, Peterlin BL, Siegel SE, Markley HG, Lipton RB. Defining refractory migraine and refractory chronic migraine: proposed criteria from the Refractory Headache Special Interest Section of the American Headache Society. Headache. 2008 Jun; 48(6):778-82.
        View in: PubMed
      161. Irimia P, Cittadini E, Paemeleire K, Cohen AS, Goadsby PJ. Unilateral photophobia or phonophobia in migraine compared with trigeminal autonomic cephalalgias. Cephalalgia. 2008 Jun; 28(6):626-30.
        View in: PubMed
      162. Goadsby PJ. Calcitonin gene-related peptide (CGRP) antagonists and migraine: is this a new era? Neurology. 2008 Apr 15; 70(16):1300-1.
        View in: PubMed
      163. Paemeleire K, Evers S, Goadsby PJ. Medication-overuse headache in patients with cluster headache. Curr Pain Headache Rep. 2008 Apr; 12(2):122-7.
        View in: PubMed
      164. Healy DG, Goadsby PJ, Kitchen ND, Yousry T, Hanna MG. Neurological picture. Spontaneous intracranial hypotension, hygromata and haematomata. J Neurol Neurosurg Psychiatry. 2008 Apr; 79(4):442.
        View in: PubMed
      165. Goadsby PJ, Zanchin G, Geraud G, de Klippel N, Diaz-Insa S, Gobel H, Cunha L, Ivanoff N, Falques M, Fortea J. Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan. Cephalalgia. 2008 Apr; 28(4):383-91.
        View in: PubMed
      166. Cittadini E, Matharu MS, Goadsby PJ. Paroxysmal hemicrania: a prospective clinical study of 31 cases. Brain. 2008 Apr; 131(Pt 4):1142-55.
        View in: PubMed
      167. Dodick DW, Lipton RB, Goadsby PJ, Tfelt-Hansen P, Ferrari MD, Diener HC, Almas M, Albert KS, Parsons B. Predictors of migraine headache recurrence: a pooled analysis from the eletriptan database. Headache. 2008 Feb; 48(2):184-93.
        View in: PubMed
      168. Goadsby PJ, Cohen AS. [Pathophysiology and treatment of trigeminal autonomic cephalalgias]. Schmerz. 2008 Feb; 22 Suppl 1:7-10.
        View in: PubMed
      169. Goadsby PJ, Bartsch T, Dodick DW. Occipital nerve stimulation for headache: mechanisms and efficacy. Headache. 2008 Feb; 48(2):313-8.
        View in: PubMed
      170. Levy MJ, Matharu M, Goadsby PJ. Chronic headache and pituitary tumors. Curr Pain Headache Rep. 2008 Jan; 12(1):74-8.
        View in: PubMed
      171. Schürks M, Diener HC, Goadsby P. Update on the prophylaxis of migraine. Curr Treat Options Neurol. 2008 Jan; 10(1):20-9.
        View in: PubMed
      172. Goadsby PJ. Neurostimulation in primary headache syndromes. Expert Rev Neurother. 2007 Dec; 7(12):1785-9.
        View in: PubMed
      173. Akerman S, Goadsby PJ. Dopamine and migraine: biology and clinical implications. Cephalalgia. 2007 Nov; 27(11):1308-14.
        View in: PubMed
      174. Goadsby PJ. Emerging therapies for migraine. Nat Clin Pract Neurol. 2007 Nov; 3(11):610-9.
        View in: PubMed
      175. Magis D, Bendtsen L, Goadsby PJ, May A, Sánchez del Rio M, Sandór PS, Kaube H, Sandrini G, Schoonman GG, Schoenen J, Afridi S. Evaluation and proposal for optimization of neurophysiological tests in migraine: part 2--neuroimaging and the nitroglycerin test. Cephalalgia. 2007 Dec; 27(12):1339-59.
        View in: PubMed
      176. Diener HC, Dodick DW, Goadsby PJ, Lipton RB, Almas M, Parsons B. Identification of negative predictors of pain-free response to triptans: analysis of the eletriptan database. Cephalalgia. 2008 Jan; 28(1):35-40.
        View in: PubMed
      177. Shapiro R, Goadsby P. The long drought: the dearth of public funding for headache research. Cephalalgia. 2007 Sep; 27(9):991-4.
        View in: PubMed
      178. Cohen AS, Matharu MS, Goadsby PJ. Electrocardiographic abnormalities in patients with cluster headache on verapamil therapy. Neurology. 2007 Aug 14; 69(7):668-75.
        View in: PubMed
      179. Holland P, Goadsby PJ. The hypothalamic orexinergic system: pain and primary headaches. Headache. 2007 Jun; 47(6):951-62.
        View in: PubMed
      180. Cohen AS, Matharu MS, Goadsby PJ. Trigeminal autonomic cephalalgias: current and future treatments. Headache. 2007 Jun; 47(6):969-80.
        View in: PubMed
      181. Bigal ME, Lipton RB, Holland PR, Goadsby PJ. Obesity, migraine, and chronic migraine: possible mechanisms of interaction. Neurology. 2007 May 22; 68(21):1851-61.
        View in: PubMed
      182. Diener HC, Bussone G, Van Oene JC, Lahaye M, Schwalen S, Goadsby PJ. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia. 2007 Jul; 27(7):814-23.
        View in: PubMed
      183. Goadsby PJ. Cortical spreading depression--better understanding and more questions. Focus on "distinct vascular conduction with cortical spreading depression". J Neurophysiol. 2007 Jun; 97(6):3827.
        View in: PubMed
      184. Gil-Gouveia R, Goadsby PJ. Secondary "hypnic headache". J Neurol. 2007 May; 254(5):646-54.
        View in: PubMed
      185. DaSilva AF, Goadsby PJ, Borsook D. Cluster headache: a review of neuroimaging findings. Curr Pain Headache Rep. 2007 Apr; 11(2):131-6.
        View in: PubMed
      186. Burns B, Watkins L, Goadsby PJ. Treatment of medically intractable cluster headache by occipital nerve stimulation: long-term follow-up of eight patients. Lancet. 2007 Mar 31; 369(9567):1099-106.
        View in: PubMed
      187. Goadsby PJ. Acromegaly. N Engl J Med. 2007 Mar 22; 356(12):1274; author reply 1275-6.
        View in: PubMed
      188. Goadsby PJ, Dodick DW, Almas M, Diener HC, Tfelt-Hansen P, Lipton RB, Parsons B. Treatment-emergent CNS symptoms following triptan therapy are part of the attack. Cephalalgia. 2007 Mar; 27(3):254-62.
        View in: PubMed
      189. Bergerot A, Storer RJ, Goadsby PJ. Dopamine inhibits trigeminovascular transmission in the rat. Ann Neurol. 2007 Mar; 61(3):251-62.
        View in: PubMed
      190. Goadsby PJ, Cohen AS, Matharu MS. Trigeminal autonomic cephalalgias: diagnosis and treatment. Curr Neurol Neurosci Rep. 2007 Mar; 7(2):117-25.
        View in: PubMed
      191. Goadsby PJ. MUMS the word. Migraine with unilateral motor symptoms: what can you say? J Neurol Neurosurg Psychiatry. 2007 Jun; 78(6):553.
        View in: PubMed
      192. Goadsby PJ. Neuromodulatory approaches to the treatment of trigeminal autonomic cephalalgias. Acta Neurochir Suppl. 2007; 97(Pt 2):99-110.
        View in: PubMed
      193. Goadsby PJ, Massiou H, Pascual J, Diener HC, Dahlöf CG, Mateos V, Dowson AJ, Raets I, Cunha L, Färkkilä M, Manzoni GC. Almotriptan and zolmitriptan in the acute treatment of migraine. Acta Neurol Scand. 2007 Jan; 115(1):34-40.
        View in: PubMed
      194. Cohen AS, Goadsby PJ. Paroxysmal hemicrania responding to topiramate. J Neurol Neurosurg Psychiatry. 2007 Jan; 78(1):96-7.
        View in: PubMed
      195. Goadsby PJ. Serotonin receptor ligands: treatments of acute migraine and cluster headache. Handb Exp Pharmacol. 2007; (177):129-43.
        View in: PubMed
      196. Frese A, Gantenbein A, Marziniak M, Husstedt IW, Goadsby PJ, Evers S. Triptans in orgasmic headache. Cephalalgia. 2006 Dec; 26(12):1458-61.
        View in: PubMed
      197. Iqbal MB, Moon JC, Guttmann OP, Shanahan P, Goadsby PJ, Holdright DR. Stress, emotion and the heart: tako-tsubo cardiomyopathy. Postgrad Med J. 2006 Dec; 82(974):e29.
        View in: PubMed
      198. Rejdak K, Empl M, Giffin NJ, Afridi SK, Petzold A, Stelmasiak Z, Thompson EJ, Goadsby PJ, Kaube H, Giovannoni G. Increased urinary excretion of nitric oxide metabolites in longitudinally monitored migraine patients. Eur J Neurol. 2006 Dec; 13(12):1346-51.
        View in: PubMed
      199. Goadsby PJ. Recent advances in understanding migraine mechanisms, molecules and therapeutics. Trends Mol Med. 2007 Jan; 13(1):39-44.
        View in: PubMed
      200. Holland PR, Akerman S, Goadsby PJ. Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat. Eur J Neurosci. 2006 Nov; 24(10):2825-33.
        View in: PubMed
      201. Gupta S, Akerman S, van den Maagdenberg AM, Saxena PR, Goadsby PJ, van den Brink AM. Intravital microscopy on a closed cranial window in mice: a model to study trigeminovascular mechanisms involved in migraine. Cephalalgia. 2006 Nov; 26(11):1294-303.
        View in: PubMed
      202. Goadsby PJ. Squeezing life into botulinum toxin A in migraine: imploding versus exploding pain. Pain. 2006 Dec 5; 125(3):206-7.
        View in: PubMed
      203. Akerman S, Holland PR, Goadsby PJ. Cannabinoid (CB1) receptor activation inhibits trigeminovascular neurons. J Pharmacol Exp Ther. 2007 Jan; 320(1):64-71.
        View in: PubMed
      204. May A, Leone M, Afra J, Linde M, Sándor PS, Evers S, Goadsby PJ. EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol. 2006 Oct; 13(10):1066-77.
        View in: PubMed
      205. Goadsby PJ. The migrainous brain: what you see is not all you get? PLoS Med. 2006 Oct; 3(10):e404.
        View in: PubMed
      206. Cittadini E, May A, Straube A, Evers S, Bussone G, Goadsby PJ. Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study. Arch Neurol. 2006 Nov; 63(11):1537-42.
        View in: PubMed
      207. Sandor PS, Irimia P, Jager HR, Goadsby PJ, Kaube H. Onset of cluster headache triggered by emotional effect: a case report. J Neurol Neurosurg Psychiatry. 2006 Sep; 77(9):1097-9.
        View in: PubMed
      208. Bergerot A, Holland PR, Akerman S, Bartsch T, Ahn AH, MaassenVanDenBrink A, Reuter U, Tassorelli C, Schoenen J, Mitsikostas DD, van den Maagdenberg AM, Goadsby PJ. Animal models of migraine: looking at the component parts of a complex disorder. Eur J Neurosci. 2006 Sep; 24(6):1517-34.
        View in: PubMed
      209. Goadsby PJ, Schoenen J, Ferrari MD, Silberstein SD, Dodick D. Towards a definition of intractable headache for use in clinical practice and trials. Cephalalgia. 2006 Sep; 26(9):1168-70.
        View in: PubMed
      210. Goadsby PJ. Migraine: emerging treatment options for preventive and acute attack therapy. Expert Opin Emerg Drugs. 2006 Sep; 11(3):419-27.
        View in: PubMed
      211. Cohen AS, Matharu MS, Goadsby PJ. Short-lasting unilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) or cranial autonomic features (SUNA)--a prospective clinical study of SUNCT and SUNA. Brain. 2006 Oct; 129(Pt 10):2746-60.
        View in: PubMed
      212. Cohen AS, Goadsby PJ. Functional neuroimaging of primary headache disorders. Expert Rev Neurother. 2006 Aug; 6(8):1159-71.
        View in: PubMed
      213. Shields KG, Goadsby PJ. Serotonin receptors modulate trigeminovascular responses in ventroposteromedial nucleus of thalamus: a migraine target? Neurobiol Dis. 2006 Sep; 23(3):491-501.
        View in: PubMed
      214. Paemeleire K, Bahra A, Evers S, Matharu MS, Goadsby PJ. Medication-overuse headache in patients with cluster headache. Neurology. 2006 Jul 11; 67(1):109-13.
        View in: PubMed
      215. Cohen AS, Gantenbein AR, Goadsby PJ. Abnormal blink reflex studies in a patient with supraorbital neuralgia. Cephalalgia. 2006 Jul; 26(7):875-8.
        View in: PubMed
      216. Paemeleire K, Crevits L, Goadsby PJ, Kaube H. Practical management of medication-overuse headache. Acta Neurol Belg. 2006 Jun; 106(2):43-51.
        View in: PubMed
      217. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia. 2006 Jun; 26(6):742-6.
        View in: PubMed
      218. EFNS guideline on the drug treatment of migraine - report of an EFNS task force. Eur J Neurol. 2006 Jun; 13(6):560-72.
        View in: PubMed
      219. Afridi SK, Goadsby PJ. Neuroimaging of migraine. Curr Pain Headache Rep. 2006 Jun; 10(3):221-4.
        View in: PubMed
      220. Le Doaré K, Akerman S, Holland PR, Lasalandra MP, Bergerot A, Classey JD, Knight YE, Goadsby PJ. Occipital afferent activation of second order neurons in the trigeminocervical complex in rat. Neurosci Lett. 2006 Jul 31; 403(1-2):73-7.
        View in: PubMed
      221. Cohen AS, Matharu MS, Goadsby PJ. Paroxysmal hemicrania in a family. Cephalalgia. 2006 Apr; 26(4):486-8.
        View in: PubMed
      222. Afridi SK, Shields KG, Bhola R, Goadsby PJ. Greater occipital nerve injection in primary headache syndromes--prolonged effects from a single injection. Pain. 2006 May; 122(1-2):126-9.
        View in: PubMed
      223. Matharu MS, Cohen AS, Frackowiak RS, Goadsby PJ. Posterior hypothalamic activation in paroxysmal hemicrania. Ann Neurol. 2006 Mar; 59(3):535-45.
        View in: PubMed
      224. Levy MJ, Classey JD, Maneesri S, Meeran K, Powell M, Goadsby PJ. The relationship between neuropeptide Y expression and headache in pituitary tumours. Eur J Neurol. 2006 Feb; 13(2):125-9.
        View in: PubMed
      225. Goadsby PJ. Recent advances in the diagnosis and management of migraine. BMJ. 2006 Jan 7; 332(7532):25-9.
        View in: PubMed
      226. Goadsby PJ, Yates R. Zolmitriptan intranasal: a review of the pharmacokinetics and clinical efficacy. Headache. 2006 Jan; 46(1):138-49.
        View in: PubMed
      227. Goadsby PJ. Headache: a good year for research. Lancet Neurol. 2006 Jan; 5(1):5-6.
        View in: PubMed
      228. Goadsby PJ. Advances in the understanding of headache. Br Med Bull. 2005; 73-74:83-92.
        View in: PubMed
      229. Holland PR, Akerman S, Goadsby PJ. Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception. J Pharmacol Exp Ther. 2005 Dec; 315(3):1380-5.
        View in: PubMed
      230. Akerman S, Goadsby PJ. Topiramate inhibits trigeminovascular activation: an intravital microscopy study. Br J Pharmacol. 2005 Sep; 146(1):7-14.
        View in: PubMed
      231. Bartsch T, Levy MJ, Knight YE, Goadsby PJ. Inhibition of nociceptive dural input in the trigeminal nucleus caudalis by somatostatin receptor blockade in the posterior hypothalamus. Pain. 2005 Sep; 117(1-2):30-9.
        View in: PubMed
      232. Goadsby PJ. Can we develop neurally acting drugs for the treatment of migraine? Nat Rev Drug Discov. 2005 Sep; 4(9):741-50.
        View in: PubMed
      233. Akerman S, Goadsby PJ. Topiramate inhibits cortical spreading depression in rat and cat: impact in migraine aura. Neuroreport. 2005 Aug 22; 16(12):1383-7.
        View in: PubMed
      234. Matharu MS, Goadsby PJ. Functional brain imaging in hemicrania continua: implications for nosology and pathophysiology. Curr Pain Headache Rep. 2005 Aug; 9(4):281-8.
        View in: PubMed
      235. Afridi S, Kaube H, Goadsby PJ. Occipital activation in glyceryl trinitrate induced migraine with visual aura. J Neurol Neurosurg Psychiatry. 2005 Aug; 76(8):1158-60.
        View in: PubMed
      236. Afridi SK, Giffin NJ, Kaube H, Friston KJ, Ward NS, Frackowiak RS, Goadsby PJ. A positron emission tomographic study in spontaneous migraine. Arch Neurol. 2005 Aug; 62(8):1270-5.
        View in: PubMed
      237. Goadsby PJ, Kullmann DM. Another migraine gene. Lancet. 2005 Jul 30-Aug 5; 366(9483):345-6.
        View in: PubMed
      238. Goadsby PJ. Trigeminal autonomic cephalalgias. Pathophysiology and classification. Rev Neurol (Paris). 2005 Jul; 161(6-7):692-5.
        View in: PubMed
      239. Cittadini E, Goadsby PJ. Psychiatric side effects during methysergide treatment. J Neurol Neurosurg Psychiatry. 2005 Jul; 76(7):1037-8.
        View in: PubMed
      240. Bolton S, O'Shaughnessy CT, Goadsby PJ. Properties of neurons in the trigeminal nucleus caudalis responding to noxious dural and facial stimulation. Brain Res. 2005 Jun 7; 1046(1-2):122-9.
        View in: PubMed
      241. Gantenbein AR, Goadsby PJ. Familial SUNCT. Cephalalgia. 2005 Jun; 25(6):457-9.
        View in: PubMed
      242. Goadsby PJ. New targets in the acute treatment of headache. Curr Opin Neurol. 2005 Jun; 18(3):283-8.
        View in: PubMed
      243. Silberstein SD, Olesen J, Bousser MG, Diener HC, Dodick D, First M, Goadsby PJ, Göbel H, Lainez MJ, Lance JW, Lipton RB, Nappi G, Sakai F, Schoenen J, Steiner TJ. The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache. Cephalalgia. 2005 Jun; 25(6):460-5.
        View in: PubMed
      244. Knight YE, Classey JD, Lasalandra MP, Akerman S, Kowacs F, Hoskin KL, Goadsby PJ. Patterns of fos expression in the rostral medulla and caudal pons evoked by noxious craniovascular stimulation and periaqueductal gray stimulation in the cat. Brain Res. 2005 May 31; 1045(1-2):1-11.
        View in: PubMed
      245. Levy MJ, Matharu MS, Meeran K, Powell M, Goadsby PJ. The clinical characteristics of headache in patients with pituitary tumours. Brain. 2005 Aug; 128(Pt 8):1921-30.
        View in: PubMed
      246. Goadsby PJ. Migraine, allodynia, sensitisation and all of that ... Eur Neurol. 2005; 53 Suppl 1:10-6.
        View in: PubMed
      247. Nathoo S, Classey JD, Levy MJ, Meeran K, Powell M, Goadsby PJ. No relationship between vasoactive intestinal polypeptide expression and headache in pituitary tumours. Acta Neurol Scand. 2005 May; 111(5):317-22.
        View in: PubMed
      248. Jäger HR, Giffin NJ, Goadsby PJ. Diffusion- and perfusion-weighted MR imaging in persistent migrainous visual disturbances. Cephalalgia. 2005 May; 25(5):323-32.
        View in: PubMed
      249. Goadsby PJ. Migraine pathophysiology. Headache. 2005 Apr; 45 Suppl 1:S14-24.
        View in: PubMed
      250. Cohen AS, Goadsby PJ. Functional neuroimaging of primary headache disorders. Curr Pain Headache Rep. 2005 Apr; 9(2):141-6.
        View in: PubMed
      251. Akerman S, Goadsby PJ. The role of dopamine in a model of trigeminovascular nociception. J Pharmacol Exp Ther. 2005 Jul; 314(1):162-9.
        View in: PubMed
      252. Ferrari MD, Goadsby PJ, Lipton RB, Dodick DW, Cutrer FM, McCrory D, Williams P. The use of multiattribute decision models in evaluating triptan treatment options in migraine. J Neurol. 2005 Sep; 252(9):1026-32.
        View in: PubMed
      253. Shams PN, Goadsby PJ, Crockard HA, Casey AT, Plant GT. Paroxysmal raised intracranial pressure associated with spinal meningeal cysts. J Neurol. 2005 Mar; 252(3):273-82.
        View in: PubMed
      254. Lipton RB, Cutrer FM, Goadsby PJ, Ferrari MD, Dodick DW, McCrory D, Liberman JN, Williams P. How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians. Curr Med Res Opin. 2005 Mar; 21(3):413-24.
        View in: PubMed
      255. Goadsby PJ. Trigeminal autonomic cephalalgias: fancy term or constructive change to the IHS classification? J Neurol Neurosurg Psychiatry. 2005 Mar; 76(3):301-5.
        View in: PubMed
      256. Afridi SK, Matharu MS, Lee L, Kaube H, Friston KJ, Frackowiak RS, Goadsby PJ. A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain. 2005 Apr; 128(Pt 4):932-9.
        View in: PubMed
      257. Goadsby PJ. Is migraine a progressive disorder? Considering the clinical implications of new research data on migraine and brain lesions. Med J Aust. 2005 Feb 7; 182(3):103-4.
        View in: PubMed
      258. Matharu MS, Goadsby PJ. Bilateral paroxysmal hemicrania or bilateral paroxysmal cephalalgia, another novel indomethacin-responsive primary headache syndrome? Cephalalgia. 2005 Feb; 25(2):79-81.
        View in: PubMed
      259. Matharu MS, van Vliet JA, Ferrari MD, Goadsby PJ. Verapamil induced gingival enlargement in cluster headache. J Neurol Neurosurg Psychiatry. 2005 Jan; 76(1):124-7.
        View in: PubMed
      260. Goadsby PJ. Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches. Drugs. 2005; 65(18):2557-67.
        View in: PubMed
      261. Shields KG, Storer RJ, Akerman S, Goadsby PJ. Calcium channels modulate nociceptive transmission in the trigeminal nucleus of the cat. Neuroscience. 2005; 135(1):203-12.
        View in: PubMed
      262. Levy MJ, Matharu MS, Bhola R, Meeran K, Goadsby PJ. Octreotide is not effective in the acute treatment of migraine. Cephalalgia. 2005 Jan; 25(1):48-55.
        View in: PubMed
      263. Shields KG, Levy MJ, Goadsby PJ. Alopecia and cutaneous atrophy after greater occipital nerve infiltration with corticosteroid. Neurology. 2004 Dec 14; 63(11):2193-4.
        View in: PubMed
      264. Storer RJ, Goadsby PJ. Topiramate inhibits trigeminovascular neurons in the cat. Cephalalgia. 2004 Dec; 24(12):1049-56.
        View in: PubMed
      265. Shields KG, Goadsby PJ. Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine? Brain. 2005 Jan; 128(Pt 1):86-97.
        View in: PubMed
      266. Dodick DW, Lipton RB, Ferrari MD, Goadsby PJ, McCrory D, Cutrer FM, Williams P. Prioritizing treatment attributes and their impact on selecting an oral triptan: results from the TRIPSTAR Project. Curr Pain Headache Rep. 2004 Dec; 8(6):435-42.
        View in: PubMed
      267. Leone M, May A, Franzini A, Broggi G, Dodick D, Rapoport A, Goadsby PJ, Schoenen J, Bonavita V, Bussone G. Deep brain stimulation for intractable chronic cluster headache: proposals for patient selection. Cephalalgia. 2004 Nov; 24(11):934-7.
        View in: PubMed
      268. Matharu MS, Cohen AS, Goadsby PJ. SUNCT syndrome responsive to intravenous lidocaine. Cephalalgia. 2004 Nov; 24(11):985-92.
        View in: PubMed
      269. Goadsby PJ. Post-triptan era for the treatment of acute migraine. Curr Pain Headache Rep. 2004 Oct; 8(5):393-8.
        View in: PubMed
      270. Matharu MS, Levy MJ, Meeran K, Goadsby PJ. Subcutaneous octreotide in cluster headache: randomized placebo-controlled double-blind crossover study. Ann Neurol. 2004 Oct; 56(4):488-94.
        View in: PubMed
      271. Goadsby PJ, Dodick DW, Ferrari MD, McCrory DC, Williams P. TRIPSTAR: prioritizing oral triptan treatment attributes in migraine management. Acta Neurol Scand. 2004 Sep; 110(3):137-43.
        View in: PubMed
      272. Matharu MS, Cohen AS, McGonigle DJ, Ward N, Frackowiak RS, Goadsby PJ. Posterior hypothalamic and brainstem activation in hemicrania continua. Headache. 2004 Sep; 44(8):747-61.
        View in: PubMed
      273. Matharu MS, Goadsby PJ. Cluster headache: focus on emerging therapies. Expert Rev Neurother. 2004 Sep; 4(5):895-907.
        View in: PubMed
      274. Bartsch T, Knight YE, Goadsby PJ. Activation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception. Ann Neurol. 2004 Sep; 56(3):371-81.
        View in: PubMed
      275. Cutrer FM, Goadsby PJ, Ferrari MD, Lipton RB, Dodick DW, McCrory D, Williams P. Priorities for triptan treatment attributes and the implications for selecting an oral triptan for acute migraine: a study of US primary care physicians (the TRIPSTAR Project). Clin Ther. 2004 Sep; 26(9):1533-45.
        View in: PubMed
      276. Goadsby PJ. To scan or not to scan in headache. BMJ. 2004 Aug 28; 329(7464):469-70.
        View in: PubMed
      277. Benjamin L, Levy MJ, Lasalandra MP, Knight YE, Akerman S, Classey JD, Goadsby PJ. Hypothalamic activation after stimulation of the superior sagittal sinus in the cat: a Fos study. Neurobiol Dis. 2004 Aug; 16(3):500-5.
        View in: PubMed
      278. Afridi SK, Kaube H, Goadsby PJ. Glyceryl trinitrate triggers premonitory symptoms in migraineurs. Pain. 2004 Aug; 110(3):675-80.
        View in: PubMed
      279. Akerman S, Kaube H, Goadsby PJ. Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors. Br J Pharmacol. 2004 Aug; 142(8):1354-60.
        View in: PubMed
      280. Storer RJ, Akerman S, Shields KG, Goadsby PJ. GABAA receptor modulation of trigeminovascular nociceptive neurotransmission by midazolam is antagonized by flumazenil. Brain Res. 2004 Jul 9; 1013(2):188-93.
        View in: PubMed
      281. Storer RJ, Akerman S, Goadsby PJ. Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br J Pharmacol. 2004 Aug; 142(7):1171-81.
        View in: PubMed
      282. Kowacs F, Williamson DJ, Goadsby PJ. Neurogenic vasodilation of dural blood vessels is not mediated by cholinergic transmission in the anaesthetised rat. Eur J Pharmacol. 2004 Jun 16; 493(1-3):133-7.
        View in: PubMed
      283. Gnanalingham KK, Watkins L, Goadsby PJ. 14 mmHg: a case of raised intracranial pressure? Br J Neurosurg. 2004 Jun; 18(3):303-6.
        View in: PubMed
      284. Bartsch T, Levy MJ, Knight YE, Goadsby PJ. Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area. Pain. 2004 Jun; 109(3):367-78.
        View in: PubMed
      285. Cohen AS, Matharu MS, Goadsby PJ. SUNCT syndrome in the elderly. Cephalalgia. 2004 Jun; 24(6):508-9.
        View in: PubMed
      286. Lipton RB, Bigal ME, Goadsby PJ. Double-blind clinical trials of oral triptans vs other classes of acute migraine medication - a review. Cephalalgia. 2004 May; 24(5):321-32.
        View in: PubMed
      287. Dodick D, Lipton RB, Martin V, Papademetriou V, Rosamond W, MaassenVanDenBrink A, Loutfi H, Welch KM, Goadsby PJ, Hahn S, Hutchinson S, Matchar D, Silberstein S, Smith TR, Purdy RA, Saiers J. Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine. Headache. 2004 May; 44(5):414-25.
        View in: PubMed
      288. Levy MJ, Jäger HR, Powell M, Matharu MS, Meeran K, Goadsby PJ. Pituitary volume and headache: size is not everything. Arch Neurol. 2004 May; 61(5):721-5.
        View in: PubMed
      289. Goadsby PJ. The future of headache. J Neurol. 2004 May; 251(5):630-6.
        View in: PubMed
      290. Afridi S, Bacon CM, Bowling J, Goadsby PJ. Verapamil and lymphomatoid papulosis in chronic cluster headache. J Neurol. 2004 Apr; 251(4):473-5.
        View in: PubMed
      291. Mitsikostas DD, Sfikakis PP, Goadsby PJ. A meta-analysis for headache in systemic lupus erythematosus: the evidence and the myth. Brain. 2004 May; 127(Pt 5):1200-9.
        View in: PubMed
      292. Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U, Pollentier S, Lesko LM. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med. 2004 Mar 11; 350(11):1104-10.
        View in: PubMed
      293. Goadsby PJ. Migraine aura: a knockin mouse with a knockout message. Neuron. 2004 Mar 4; 41(5):679-80.
        View in: PubMed
      294. Bahra A, Goadsby PJ. Diagnostic delays and mis-management in cluster headache. Acta Neurol Scand. 2004 Mar; 109(3):175-9.
        View in: PubMed
      295. Cohen AS, Goadsby PJ. Functional neuroimaging of primary headache disorders. Curr Neurol Neurosci Rep. 2004 Mar; 4(2):105-10.
        View in: PubMed
      296. Akerman S, Kaube H, Goadsby PJ. Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception. J Pharmacol Exp Ther. 2004 Apr; 309(1):56-63.
        View in: PubMed
      297. Levy MJ, Classey JD, Maneesri S, Meeran K, Powell M, Goadsby PJ. The association between calcitonin gene-related peptide (CGRP), substance P and headache in pituitary tumours. Pituitary. 2004; 7(2):67-71.
        View in: PubMed
      298. Matharu MS, Bartsch T, Ward N, Frackowiak RS, Weiner R, Goadsby PJ. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain. 2004 Jan; 127(Pt 1):220-30.
        View in: PubMed
      299. Matharu MS, Levy MJ, Merry RT, Goadsby PJ. SUNCT syndrome secondary to prolactinoma. J Neurol Neurosurg Psychiatry. 2003 Nov; 74(11):1590-2.
        View in: PubMed
      300. Goadsby PJ. Surgical treatment of chronic cluster headache. Headache. 2003 Nov-Dec; 43(10):1118; author reply 1118-9.
        View in: PubMed
      301. Levy MJ, Knight YE, O'Shaughnessy CT, Goadsby PJ. Effect of IL-1beta microinjection into the posterior hypothalamic area on trigeminal nociception in the rat. J Neural Transm. 2003 Dec; 110(12):1349-58.
        View in: PubMed
      302. Knight YE, Levy MJ, O'Shaughnessy CT, Goadsby PJ. Prostaglandin E2 injected into the posterior hypothalamus has no effect on trigeminal nociception in the rat. Neurosci Lett. 2003 Oct 23; 350(2):85-8.
        View in: PubMed
      303. Akerman S, Kaube H, Goadsby PJ. Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation. Br J Pharmacol. 2003 Oct; 140(4):718-24.
        View in: PubMed
      304. Bartsch T, Goadsby PJ. The trigeminocervical complex and migraine: current concepts and synthesis. Curr Pain Headache Rep. 2003 Oct; 7(5):371-6.
        View in: PubMed
      305. Goadsby PJ. Migraine: diagnosis and management. Intern Med J. 2003 Sep-Oct; 33(9-10):436-42.
        View in: PubMed
      306. Nilsson Remahl AI, Laudon Meyer E, Cordonnier C, Goadsby PJ. Placebo response in cluster headache trials: a review. Cephalalgia. 2003 Sep; 23(7):504-10.
        View in: PubMed
      307. Akerman S, Williamson DJ, Goadsby PJ. Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism. Br J Pharmacol. 2003 Oct; 140(3):558-66.
        View in: PubMed
      308. Matharu MS, Cohen AS, Boes CJ, Goadsby PJ. Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing syndrome: a review. Curr Pain Headache Rep. 2003 Aug; 7(4):308-18.
        View in: PubMed
      309. Goadsby PJ, Ferrari MD, Lipton RB. Therapeutic gain or therapeutic ratio? Headache. 2003 Jul-Aug; 43(7):814-5; author reply 815-6.
        View in: PubMed
      310. Levy MJ, Bejon P, Barakat M, Goadsby PJ, Meeran K. Acromegaly: a unique human headache model. Headache. 2003 Jul-Aug; 43(7):794-7.
        View in: PubMed
      311. Bartsch T, Goadsby PJ. Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater. Brain. 2003 Aug; 126(Pt 8):1801-13.
        View in: PubMed
      312. Goadsby P, Jager HR. Postural headache and cerebrospinal fluid leak: believing is seeing. Headache. 2003 Jun; 43(6):681; discussion 681.
        View in: PubMed
      313. Afridi S, Goadsby PJ. New onset migraine with a brain stem cavernous angioma. J Neurol Neurosurg Psychiatry. 2003 May; 74(5):680-2.
        View in: PubMed
      314. Giffin NJ, Kowacs F, Libri V, Williams P, Goadsby PJ, Kaube H. Effect of the adenosine A1 receptor agonist GR79236 on trigeminal nociception with blink reflex recordings in healthy human subjects. Cephalalgia. 2003 May; 23(4):287-92.
        View in: PubMed
      315. Kowacs F, Giffin NJ, Putzki N, Goadsby PJ, Kaube H. Nociceptive-specific blink reflex and glyceryl trinitrate infusion in healthy volunteers. Eur J Neurol. 2003 May; 10(3):295-9.
        View in: PubMed
      316. Lipton RB, Silberstein SD, Saper JR, Bigal ME, Goadsby PJ. Why headache treatment fails. Neurology. 2003 Apr 8; 60(7):1064-70.
        View in: PubMed
      317. Silber E, Sonnenberg P, Collier DJ, Pollard AJ, Murdoch DR, Goadsby PJ. Clinical features of headache at altitude: a prospective study. Neurology. 2003 Apr 8; 60(7):1167-71.
        View in: PubMed
      318. Levy MJ, Matharu MS, Bhola R, Lightman S, Goadsby PJ. Somatostatin infusion withdrawal: a study of patients with migraine, cluster headache and healthy volunteers. Pain. 2003 Apr; 102(3):235-41.
        View in: PubMed
      319. Giffin NJ, Ruggiero L, Lipton RB, Silberstein SD, Tvedskov JF, Olesen J, Altman J, Goadsby PJ, Macrae A. Premonitory symptoms in migraine: an electronic diary study. Neurology. 2003 Mar 25; 60(6):935-40.
        View in: PubMed
      320. Evers S, Goadsby PJ. Hypnic headache: clinical features, pathophysiology, and treatment. Neurology. 2003 Mar 25; 60(6):905-9.
        View in: PubMed
      321. Levy MJ, Matharu MS, Goadsby PJ. Prolactinomas, dopamine agonists and headache: two case reports. Eur J Neurol. 2003 Mar; 10(2):169-73.
        View in: PubMed
      322. Bahra A, Walsh M, Menon S, Goadsby PJ. Does chronic daily headache arise de novo in association with regular use of analgesics? Headache. 2003 Mar; 43(3):179-90.
        View in: PubMed
      323. Goadsby PJ. Sporadic hemiplegic migraine: stamp collecting or food for thought? Neurology. 2003 Feb 25; 60(4):536-7.
        View in: PubMed
      324. van Vliet JA, Bahra A, Martin V, Ramadan N, Aurora SK, Mathew NT, Ferrari MD, Goadsby PJ. Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study. Neurology. 2003 Feb 25; 60(4):630-3.
        View in: PubMed
      325. Boes CJ, Matharu MS, Goadsby PJ. The paroxysmal hemicrania-tic syndrome. Cephalalgia. 2003 Feb; 23(1):24-8.
        View in: PubMed
      326. Knight YE, Bartsch T, Goadsby PJ. Trigeminal antinociception induced by bicuculline in the periaqueductal gray (PAG) is not affected by PAG P/Q-type calcium channel blockade in rat. Neurosci Lett. 2003 Jan 16; 336(2):113-6.
        View in: PubMed
      327. Storer RJ, Akerman S, Goadsby PJ. Characterization of opioid receptors that modulate nociceptive neurotransmission in the trigeminocervical complex. Br J Pharmacol. 2003 Jan; 138(2):317-24.
        View in: PubMed
      328. Matharu MS, Boes CJ, Goadsby PJ. Management of trigeminal autonomic cephalgias and hemicrania continua. Drugs. 2003; 63(16):1637-77.
        View in: PubMed
      329. Matharu MS, Good CD, May A, Bahra A, Goadsby PJ. No change in the structure of the brain in migraine: a voxel-based morphometric study. Eur J Neurol. 2003 Jan; 10(1):53-7.
        View in: PubMed
      330. Goadsby PJ, Classey JD. Evidence for serotonin (5-HT)1B, 5-HT1D and 5-HT1F receptor inhibitory effects on trigeminal neurons with craniovascular input. Neuroscience. 2003; 122(2):491-8.
        View in: PubMed
      331. Boes CJ, Matharu MS, Goadsby PJ. Benign cough headache. Cephalalgia. 2002 Dec; 22(10):772-9.
        View in: PubMed
      332. Akerman S, Williamson DJ, Kaube H, Goadsby PJ. The role of histamine in dural vessel dilation. Brain Res. 2002 Nov 22; 956(1):96-102.
        View in: PubMed
      333. Bartsch T, Akerman S, Goadsby PJ. The ORL-1 (NOP1) receptor ligand nociceptin/orphanin FQ (N/OFQ) inhibits neurogenic dural vasodilatation in the rat. Neuropharmacology. 2002 Nov; 43(6):991-8.
        View in: PubMed
      334. Akerman S, Williamson DJ, Kaube H, Goadsby PJ. The effect of anti-migraine compounds on nitric oxide-induced dilation of dural meningeal vessels. Eur J Pharmacol. 2002 Oct 4; 452(2):223-8.
        View in: PubMed
      335. Ferrari MD, Goadsby PJ, Roon KI, Lipton RB. Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia. 2002 Oct; 22(8):633-58.
        View in: PubMed
      336. Akerman S, Williamson DJ, Kaube H, Goadsby PJ. Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels. Br J Pharmacol. 2002 Sep; 137(1):62-8.
        View in: PubMed
      337. Silberstein SD, Goadsby PJ. Migraine: preventive treatment. Cephalalgia. 2002 Sep; 22(7):491-512.
        View in: PubMed
      338. Goadsby PJ, Lipton RB. The hemicrania continua diagnosis. Cephalalgia. 2002 Sep; 22(7):563-4; author reply 564-5.
        View in: PubMed
      339. Goadsby PJ. Pathophysiology of cluster headache: a trigeminal autonomic cephalgia. Lancet Neurol. 2002 Aug; 1(4):251-7.
        View in: PubMed
      340. Giffin NJ, Benton S, Goadsby PJ. Benign paroxysmal torticollis of infancy: four new cases and linkage to CACNA1A mutation. Dev Med Child Neurol. 2002 Jul; 44(7):490-3.
        View in: PubMed
      341. Bartsch T, Goadsby PJ. Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input. Brain. 2002 Jul; 125(Pt 7):1496-509.
        View in: PubMed
      342. Goadsby PJ. New directions in migraine research. J Clin Neurosci. 2002 Jul; 9(4):368-73.
        View in: PubMed
      343. Welch KM, Goadsby PJ. Chronic daily headache: nosology and pathophysiology. Curr Opin Neurol. 2002 Jun; 15(3):287-95.
        View in: PubMed
      344. Goadsby PJ, Boes C. New daily persistent headache. J Neurol Neurosurg Psychiatry. 2002 Jun; 72 Suppl 2:ii6-ii9.
        View in: PubMed
      345. Matharu MS, Goadsby PJ. Trigeminal autonomic cephalgias. J Neurol Neurosurg Psychiatry. 2002 Jun; 72 Suppl 2:ii19-ii26.
        View in: PubMed
      346. Goadsby PJ. Headache. Curr Opin Neurol. 2002 Jun; 15(3):285-6.
        View in: PubMed
      347. Goadsby PJ, Boes C. Chronic daily headache. J Neurol Neurosurg Psychiatry. 2002 Jun; 72 Suppl 2:ii2-ii5.
        View in: PubMed
      348. Goadsby PJ, Hoskin KL, Storer RJ, Edvinsson L, Connor HE. Adenosine A1 receptor agonists inhibit trigeminovascular nociceptive transmission. Brain. 2002 Jun; 125(Pt 6):1392-401.
        View in: PubMed
      349. Boes CJ, Capobianco DJ, Matharu MS, Goadsby PJ. Wilfred Harris' early description of cluster headache. Cephalalgia. 2002 May; 22(4):320-6.
        View in: PubMed
      350. Matharu MS, Goadsby PJ. Persistence of attacks of cluster headache after trigeminal nerve root section. Brain. 2002 May; 125(Pt 5):976-84.
        View in: PubMed
      351. Matharu MS, Boes CJ, Goadsby PJ. SUNCT syndrome: prolonged attacks, refractoriness and response to topiramate. Neurology. 2002 Apr 23; 58(8):1307.
        View in: PubMed
      352. Matharu MS, Levy MJ, Goadsby PJ. Understanding migraine in women. Practitioner. 2002 Apr; 246(1633):272-8.
        View in: PubMed
      353. Goadsby PJ. Neurovascular headache and a midbrain vascular malformation: evidence for a role of the brainstem in chronic migraine. Cephalalgia. 2002 Mar; 22(2):107-11.
        View in: PubMed
      354. Goadsby PJ. Raeder's syndrome [corrected]: paratrigeminal paralysis of the oculopupillary sympathetic system. J Neurol Neurosurg Psychiatry. 2002 Mar; 72(3):297-9.
        View in: PubMed
      355. Knight YE, Bartsch T, Kaube H, Goadsby PJ. P/Q-type calcium-channel blockade in the periaqueductal gray facilitates trigeminal nociception: a functional genetic link for migraine? J Neurosci. 2002 Mar 1; 22(5):RC213.
        View in: PubMed
      356. Bahra A, May A, Goadsby PJ. Cluster headache: a prospective clinical study with diagnostic implications. Neurology. 2002 Feb 12; 58(3):354-61.
        View in: PubMed
      357. Goadsby PJ, Lipton RB, Ferrari MD. Migraine--current understanding and treatment. N Engl J Med. 2002 Jan 24; 346(4):257-70.
        View in: PubMed
      358. Goadsby PJ. Migraine management: contrasting patient preferences with current clinical end points: introduction. Headache. 2002 Jan; 42 Suppl 1:1-2.
        View in: PubMed
      359. Giffin NJ, Goadsby PJ. Basilar artery aneurysm with autonomic features: an interesting pathophysiological problem. J Neurol Neurosurg Psychiatry. 2001 Dec; 71(6):805-8.
        View in: PubMed
      360. Goadsby PJ, Akerman S, Storer RJ. Evidence for postjunctional serotonin (5-HT1) receptors in the trigeminocervical complex. Ann Neurol. 2001 Dec; 50(6):804-7.
        View in: PubMed
      361. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet. 2001 Nov 17; 358(9294):1668-75.
        View in: PubMed
      362. Storer RJ, Akerman S, Goadsby PJ. GABA receptors modulate trigeminovascular nociceptive neurotransmission in the trigeminocervical complex. Br J Pharmacol. 2001 Oct; 134(4):896-904.
        View in: PubMed
      363. May A, Büchel C, Turner R, Goadsby PJ. Magnetic resonance angiography in facial and other pain: neurovascular mechanisms of trigeminal sensation. J Cereb Blood Flow Metab. 2001 Oct; 21(10):1171-6.
        View in: PubMed
      364. Lipton RB, Pascual J, Goadsby PJ, Massiou H, McCarroll KA, Vandormael K, Jiang K, Lines CR. Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis. Headache. 2001 Sep; 41(8):754-63.
        View in: PubMed
      365. Classey JD, Knight YE, Goadsby PJ. The NMDA receptor antagonist MK-801 reduces Fos-like immunoreactivity within the trigeminocervical complex following superior sagittal sinus stimulation in the cat. Brain Res. 2001 Jul 13; 907(1-2):117-24.
        View in: PubMed
      366. Akerman S, Williamson DJ, Hill RG, Goadsby PJ. The effect of adrenergic compounds on neurogenic dural vasodilatation. Eur J Pharmacol. 2001 Jul 13; 424(1):53-8.
        View in: PubMed
      367. Newman LC, Goadsby P, Lipton RB. Cluster and related headaches. Med Clin North Am. 2001 Jul; 85(4):997-1016.
        View in: PubMed
      368. Matharu MS, Boes CJ, Goadsby PJ. Managing the patient with migraine. Practitioner. 2001 Jun; 245(1623):511, 515-8, 521 passim.
        View in: PubMed
      369. Goadsby PJ, Lipton RB. Paroxysmal hemicrania-tic syndrome. Headache. 2001 Jun; 41(6):608-9.
        View in: PubMed
      370. May A, Goadsby PJ. Pharmacological opportunities and pitfalls in the therapy of migraine. Curr Opin Neurol. 2001 Jun; 14(3):341-5.
        View in: PubMed
      371. Storer RJ, Akerman S, Connor HE, Goadsby PJ. 4991W93, a potent blocker of neurogenic plasma protein extravasation, inhibits trigeminal neurons at 5-hydroxytryptamine (5-HT1B/1D) agonist doses. Neuropharmacology. 2001 Jun; 40(7):911-7.
        View in: PubMed
      372. Goadsby PJ. Neuroimaging in headache. Microsc Res Tech. 2001 May 1; 53(3):179-87.
        View in: PubMed
      373. Edvinsson L, Goadsby PJ, Uddman R. Amylin: localization, effects on cerebral arteries and on local cerebral blood flow in the cat. ScientificWorldJournal. 2001 May 1; 1:168-80.
        View in: PubMed
      374. May A, Goadsby PJ. Substance P receptor antagonists in the therapy of migraine. Expert Opin Investig Drugs. 2001 Apr; 10(4):673-8.
        View in: PubMed
      375. Goadsby PJ. Trigeminal autonomic cephalgias (TACs). Acta Neurol Belg. 2001 Mar; 101(1):10-9.
        View in: PubMed
      376. Goadsby PJ, Matharu MS, Boes CJ. SUNCT syndrome or trigeminal neuralgia with lacrimation. Cephalalgia. 2001 Mar; 21(2):82-3.
        View in: PubMed
      377. Knight YE, Edvinsson L, Goadsby PJ. 4991W93 inhibits release of calcitonin gene-related peptide in the cat but only at doses with 5HT(1B/1D) receptor agonist activity? Neuropharmacology. 2001 Mar; 40(4):520-5.
        View in: PubMed
      378. ter Berg JW, Goadsby PJ. Significance of atypical presentation of symptomatic SUNCT: a case report. J Neurol Neurosurg Psychiatry. 2001 Feb; 70(2):244-6.
        View in: PubMed
      379. May A, Goadsby PJ. Hypothalamic involvement and activation in cluster headache. Curr Pain Headache Rep. 2001 Feb; 5(1):60-6.
        View in: PubMed
      380. Matharu MJ, Goadsby PJ. Post-traumatic chronic paroxysmal hemicrania (CPH) with aura. Neurology. 2001 Jan 23; 56(2):273-5.
        View in: PubMed
      381. Goadsby PJ. Migraine, aura, and cortical spreading depression: why are we still talking about it? Ann Neurol. 2001 Jan; 49(1):4-6.
        View in: PubMed
      382. Lipton RB, Stewart WF, Goadsby PJ. Headache-related disability in the management of migraine. Neurology. 2001; 56(6 Suppl 1):S1-3.
        View in: PubMed
      383. Goadsby PJ. Migraine: selecting treatments now and making requests for the future? Curr Med Res Opin. 2001; 17 Suppl 1:s98-9.
        View in: PubMed
      384. Hoskin KL, Bulmer DC, Lasalandra M, Jonkman A, Goadsby PJ. Fos expression in the midbrain periaqueductal grey after trigeminovascular stimulation. J Anat. 2001 Jan; 198(Pt 1):29-35.
        View in: PubMed
      385. Knight YE, Goadsby PJ. The periaqueductal grey matter modulates trigeminovascular input: a role in migraine? Neuroscience. 2001; 106(4):793-800.
        View in: PubMed
      386. Goadsby PJ, Boes CJ. Zolmitriptan: differences from sumatriptan. Curr Med Res Opin. 2001; 17 Suppl 1:s46-50.
        View in: PubMed
      387. Goadsby PJ. The pharmacology of headache. Prog Neurobiol. 2000 Dec; 62(5):509-25.
        View in: PubMed
      388. May A, Bahra A, Büchel C, Frackowiak RS, Goadsby PJ. PET and MRA findings in cluster headache and MRA in experimental pain. Neurology. 2000 Nov 14; 55(9):1328-35.
        View in: PubMed
      389. Tfelt-Hansen P, Block G, Dahlöf C, Diener HC, Ferrari MD, Goadsby PJ, Guidetti V, Jones B, Lipton RB, Massiou H, Meinert C, Sandrini G, Steiner T, Winter PB. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia. 2000 Nov; 20(9):765-86.
        View in: PubMed
      390. Dodick DW, Rozen TD, Goadsby PJ, Silberstein SD. Cluster headache. Cephalalgia. 2000 Nov; 20(9):787-803.
        View in: PubMed
      391. Millson D, Frischer M, Croft P, Goadsby PJ. Are triptans with enhanced lipophilicity used for the acute treatment of migraine associated with an increased consulting rate for depressive illness? Cephalalgia. 2000 Oct; 20(8):732-7.
        View in: PubMed
      392. Goadsby PJ, Classey JD. Glutamatergic transmission in the trigeminal nucleus assessed with local blood flow. Brain Res. 2000 Sep 1; 875(1-2):119-24.
        View in: PubMed
      393. Goadsby PJ. Re: Donnan GA, Davis SM 'Neurology: reflections on the past millennium as we enter the next", Journal of Clinical Neuroscience 2000;7:1-2. J Clin Neurosci. 2000 Jul; 7(4):377.
        View in: PubMed
      394. Bahra A, Gawel MJ, Hardebo JE, Millson D, Breen SA, Goadsby PJ. Oral zolmitriptan is effective in the acute treatment of cluster headache. Neurology. 2000 May 9; 54(9):1832-9.
        View in: PubMed
      395. Goadsby PJ. Migraine treatment and mistreatment: primum non nocere. Med J Aust. 2000 May 1; 172(9):412-3.
        View in: PubMed
      396. Goadsby PJ, Ferrari MD, Olesen J, Stovner LJ, Senard JM, Jackson NC, Poole PH. Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee. Neurology. 2000 Jan 11; 54(1):156-63.
        View in: PubMed
      397. Goadsby PJ. Rizatriptan in acute treatment of migraine: update on new comparative data. Cephalalgia. 2000; 20 Suppl 1:10-5.
        View in: PubMed
      398. Tfelt-Hansen P, Saxena PR, Dahlöf C, Pascual J, Láinez M, Henry P, Diener H, Schoenen J, Ferrari MD, Goadsby PJ. Ergotamine in the acute treatment of migraine: a review and European consensus. Brain. 2000 Jan; 123 ( Pt 1):9-18.
        View in: PubMed
      399. Goadsby PJ, Lipton RB. Newer triptans: emphasis on rizatriptan. Neurology. 2000; 55(9 Suppl 2):S1-2.
        View in: PubMed
      400. Goadsby PJ, Hargreaves RJ. Mechanisms of action of serotonin 5-HT1B/D agonists: insights into migraine pathophysiology using rizatriptan. Neurology. 2000; 55(9 Suppl 2):S8-14.
        View in: PubMed
      401. Silberstein SD, Goadsby PJ, Lipton RB. Management of migraine: an algorithmic approach. Neurology. 2000; 55(9 Suppl 2):S46-52.
        View in: PubMed
      402. Goadsby PJ. Cluster headache: new perspectives. Cephalalgia. 1999 Dec; 19 Suppl 25:39-41.
        View in: PubMed
      403. Goadsby PJ. Advances in the pharmacotherapy of migraine. How knowledge of pathophysiology is guiding drug development. Drugs R D. 1999 Dec; 2(6):361-74.
        View in: PubMed
      404. Goadsby PJ. The scientific basis of medication choice in symptomatic migraine treatment. Can J Neurol Sci. 1999 Nov; 26 Suppl 3:S20-6.
        View in: PubMed
      405. May A, Bahra A, Büchel C, Turner R, Goadsby PJ. Functional magnetic resonance imaging in spontaneous attacks of SUNCT: short-lasting neuralgiform headache with conjunctival injection and tearing. Ann Neurol. 1999 Nov; 46(5):791-4.
        View in: PubMed
      406. Goadsby PJ. Chronic tension-type headache: where are we? Brain. 1999 Sep; 122 ( Pt 9):1611-2.
        View in: PubMed
      407. May A, Ashburner J, Büchel C, McGonigle DJ, Friston KJ, Frackowiak RS, Goadsby PJ. Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat Med. 1999 Jul; 5(7):836-8.
        View in: PubMed
      408. Goadsby PJ, Hoskin KL. Differential effects of low dose CP122,288 and eletriptan on fos expression due to stimulation of the superior sagittal sinus in cat. Pain. 1999 Jul; 82(1):15-22.
        View in: PubMed
      409. Allen C, Jiang K, Malbecq W, Goadsby PJ. Time-to-event analysis, or who gets better sooner? An emerging concept in headache study methodology. Cephalalgia. 1999 Jul; 19(6):552-6.
        View in: PubMed
      410. Kaube H, Knight YE, Storer RJ, Hoskin KL, May A, Goadsby PJ. Vasodilator agents and supracollicular transection fail to inhibit cortical spreading depression in the cat. Cephalalgia. 1999 Jul; 19(6):592-7.
        View in: PubMed
      411. Goadsby PJ. Short-lasting primary headaches: focus on trigeminal automatic cephalgias and indomethacin-sensitive headaches. Curr Opin Neurol. 1999 Jun; 12(3):273-7.
        View in: PubMed
      412. Evers S, Bahra A, Goadsby PJ. Coincidence of familial hemiplegic migraine and hemicrania continua? A case report. Cephalalgia. 1999 Jun; 19(5):533-5.
        View in: PubMed
      413. Hoskin KL, Bulmer DC, Goadsby PJ. Fos expression in the trigeminocervical complex of the cat after stimulation of the superior sagittal sinus is reduced by L-NAME. Neurosci Lett. 1999 May 14; 266(3):173-6.
        View in: PubMed
      414. Hoskin KL, Zagami AS, Goadsby PJ. Stimulation of the middle meningeal artery leads to Fos expression in the trigeminocervical nucleus: a comparative study of monkey and cat. J Anat. 1999 May; 194 ( Pt 4):579-88.
        View in: PubMed
      415. Goadsby PJ. Mechanisms and management of headache. J R Coll Physicians Lond. 1999 May-Jun; 33(3):228-34.
        View in: PubMed
      416. May A, Büchel C, Bahra A, Goadsby PJ, Frackowiak RS. Intracranial vessels in trigeminal transmitted pain: A PET study. Neuroimage. 1999 May; 9(5):453-60.
        View in: PubMed
      417. Goadsby PJ, May A. PET demonstration of hypothalamic activation in cluster headache. Neurology. 1999 Apr 22; 52(7):1522.
        View in: PubMed
      418. Tfelt-Hansen P, Goadsby PJ. Naratriptan is effective and well tolerated in the acute treatment of migraine. Neurology. 1999 Apr 12; 52(6):1300-1.
        View in: PubMed
      419. Hoskin KL, Goadsby PJ. Exposure and isolation of the superior sagittal sinus elicits Fos in the trigeminal nucleus caudalis and dorsal horn of the cervical spinal cord: how long should you wait? Brain Res. 1999 Apr 3; 824(1):133-5.
        View in: PubMed
      420. Goadsby PJ. Evidence for hypothalamic activation in cluster headache. Ital J Neurol Sci. 1999 Apr; 20(2 Suppl):S80-3.
        View in: PubMed
      421. Goadsby PJ, Bahra A, May A. Mechanisms of cluster headache. Cephalalgia. 1999 Mar; 19 Suppl 23:19-21; discussion 21-3.
        View in: PubMed
      422. May A, Goadsby PJ. The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab. 1999 Feb; 19(2):115-27.
        View in: PubMed
      423. Knight YE, Edvinsson L, Goadsby PJ. Blockade of calcitonin gene-related peptide release after superior sagittal sinus stimulation in cat: a comparison of avitriptan and CP122,288. Neuropeptides. 1999 Feb; 33(1):41-6.
        View in: PubMed
      424. Storer RJ, Goadsby PJ. Trigeminovascular nociceptive transmission involves N-methyl-D-aspartate and non-N-methyl-D-aspartate glutamate receptors. Neuroscience. 1999; 90(4):1371-6.
        View in: PubMed
      425. Uddman R, Goadsby PJ, Jansen-Olesen I, Edvinsson L. Helospectin-like peptides: immunochemical localization and effects on isolated cerebral arteries and on local cerebral blood flow in the cat. J Cereb Blood Flow Metab. 1999 Jan; 19(1):61-7.
        View in: PubMed
      426. Lipton RB, Goadsby P, Silberstein SD. Classification and epidemiology of headache. Clin Cornerstone. 1999; 1(6):1-10.
        View in: PubMed
      427. Goadsby PJ. Sumatriptan is not the only analgesic used inappropriately. BMJ. 1998 Oct 10; 317(7164):1016.
        View in: PubMed
      428. Bahra A, Goadsby PJ. Cough headache responsive to methysergide. Cephalalgia. 1998 Sep; 18(7):495-6.
        View in: PubMed
      429. Goadsby PJ, Hoskin KL, Knight YE. Substance P blockade with the potent and centrally acting antagonist GR205171 does not effect central trigeminal activity with superior sagittal sinus stimulation. Neuroscience. 1998 Sep; 86(1):337-43.
        View in: PubMed
      430. May A, Bahra A, Büchel C, Frackowiak RS, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet. 1998 Jul 25; 352(9124):275-8.
        View in: PubMed
      431. Peatfield R, Bahra A, Goadsby PJ. Trigeminal-autonomic cephalgias (TACs) Cephalalgia. 1998 Jul-Aug; 18(6):358.
        View in: PubMed
      432. May A, Shepheard SL, Knorr M, Effert R, Wessing A, Hargreaves RJ, Goadsby PJ, Diener HC. Retinal plasma extravasation in animals but not in humans: implications for the pathophysiology of migraine. Brain. 1998 Jul; 121 ( Pt 7):1231-7.
        View in: PubMed
      433. May A, Goadsby PJ. Cluster headache: imaging and other developments. Curr Opin Neurol. 1998 Jun; 11(3):199-203.
        View in: PubMed
      434. Goadsby PJ, Hoskin KL. Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: a central action in migraine? Ann Neurol. 1998 Jun; 43(6):711-8.
        View in: PubMed
      435. Edvinsson L, Mulder H, Goadsby PJ, Uddman R. Calcitonin gene-related peptide and nitric oxide in the trigeminal ganglion: cerebral vasodilatation from trigeminal nerve stimulation involves mainly calcitonin gene-related peptide. J Auton Nerv Syst. 1998 May 28; 70(1-2):15-22.
        View in: PubMed
      436. Nyholt DR, Lea RA, Goadsby PJ, Brimage PJ, Griffiths LR. Familial typical migraine: linkage to chromosome 19p13 and evidence for genetic heterogeneity. Neurology. 1998 May; 50(5):1428-32.
        View in: PubMed
      437. Grunfeld EA, Price C, Goadsby PJ, Gresty MA. Motion sickness, migraine, and menstruation in mariners. Lancet. 1998 Apr 11; 351(9109):1106.
        View in: PubMed
      438. Hoskin KL, Goadsby PJ. Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat. Exp Neurol. 1998 Mar; 150(1):45-51.
        View in: PubMed
      439. Goadsby PJ. A triptan too far? J Neurol Neurosurg Psychiatry. 1998 Feb; 64(2):143-7.
        View in: PubMed
      440. Goadsby PJ, Fields HL. On the functional anatomy of migraine. Ann Neurol. 1998 Feb; 43(2):272.
        View in: PubMed
      441. Goadsby PJ. Serotonin receptors and the acute attack of migraine. Clin Neurosci. 1998; 5(1):18-23.
        View in: PubMed
      442. Storer RJ, Goadsby PJ. Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat. Brain. 1997 Dec; 120 ( Pt 12):2171-7.
        View in: PubMed
      443. Storer RJ, Butler P, Hoskin KL, Goadsby PJ. A simple method, using 2-hydroxypropyl-beta-cyclodextrin, of administering alpha-chloralose at room temperature. J Neurosci Methods. 1997 Nov 7; 77(1):49-53.
        View in: PubMed
      444. Goadsby PJ, Knight Y. Inhibition of trigeminal neurones after intravenous administration of naratriptan through an action at 5-hydroxy-tryptamine (5-HT(1B/1D)) receptors. Br J Pharmacol. 1997 Nov; 122(5):918-22.
        View in: PubMed
      445. Goadsby PJ, Knight YE, Hoskin KL. Stimulation of the greater occipital nerve increases metabolic activity in the trigeminal nucleus caudalis and cervical dorsal horn of the cat. Pain. 1997 Oct; 73(1):23-8.
        View in: PubMed
      446. Griffiths LR, Nyholt DR, Curtain RP, Goadsby PJ, Brimage PJ. Migraine association and linkage studies of an endothelial nitric oxide synthase (NOS3) gene polymorphism. Neurology. 1997 Aug; 49(2):614-7.
        View in: PubMed
      447. Goadsby PJ. Bench to bedside: what have we learnt recently about headache? Curr Opin Neurol. 1997 Jun; 10(3):215-20.
        View in: PubMed
      448. Goadsby PJ. Is a central action of acute antimigraine drugs essential? Cephalalgia. 1997 Jun; 17 Suppl 17:10-1.
        View in: PubMed
      449. Goadsby PJ, Knight YE. Direct evidence for central sites of action of zolmitriptan (311C90): an autoradiographic study in cat. Cephalalgia. 1997 May; 17(3):153-8.
        View in: PubMed
      450. Goadsby PJ. How do the currently used prophylactic agents work in migraine? Cephalalgia. 1997 Apr; 17(2):85-92.
        View in: PubMed
      451. Goadsby PJ, Hoskin KL. The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: a c-fos immunocytochemical study. J Anat. 1997 Apr; 190 ( Pt 3):367-75.
        View in: PubMed
      452. Goadsby PJ, Knight YE, Hoskin KL, Butler P. Stimulation of an intracranial trigeminally-innervated structure selectively increases cerebral blood flow. Brain Res. 1997 Mar 21; 751(2):247-52.
        View in: PubMed
      453. Goadsby PJ, Olesen J. Increasing the options for effective migraine management. Neurology. 1997 Mar; 48(3 Suppl 3):S1-3.
        View in: PubMed
      454. Goadsby PJ. Current concepts of the pathophysiology of migraine. Neurol Clin. 1997 Feb; 15(1):27-42.
        View in: PubMed
      455. Goadsby PJ, Lipton RB. A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases. Brain. 1997 Jan; 120 ( Pt 1):193-209.
        View in: PubMed
      456. Nyholt DR, Curtain RP, Gaffney PT, Brimage P, Goadsby PJ, Griffiths LR. Migraine association and linkage analyses of the human 5-hydroxytryptamine (5HT2A) receptor gene. Cephalalgia. 1996 Nov; 16(7):463-7.
        View in: PubMed
      457. Goadsby PJ, Edvinsson L. Neuropeptide changes in a case of chronic paroxysmal hemicrania--evidence for trigemino-parasympathetic activation. Cephalalgia. 1996 Oct; 16(6):448-50.
        View in: PubMed
      458. Hoskin KL, Kaube H, Goadsby PJ. Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism. Brain. 1996 Oct; 119 ( Pt 5):1419-28.
        View in: PubMed
      459. Jacob J, Goadsby PJ, Duncan JS. Use of sumatriptan in post-ictal migraine headache. Neurology. 1996 Oct; 47(4):1104.
        View in: PubMed
      460. Goadsby PJ, Hoskin KL. Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): are brain stem sites therapeutic target in migraine? Pain. 1996 Oct; 67(2-3):355-9.
        View in: PubMed
      461. Goadsby PJ, Adner M, Edvinsson L. Characterization of endothelin receptors in the cerebral vasculature and their lack of effect on spreading depression. J Cereb Blood Flow Metab. 1996 Jul; 16(4):698-704.
        View in: PubMed
      462. Goadsby PJ, Olesen J. Diagnosis and management of migraine. BMJ. 1996 May 18; 312(7041):1279-83.
        View in: PubMed
      463. Hoskin KL, Kaube H, Goadsby PJ. Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study. Brain. 1996 Feb; 119 ( Pt 1):249-56.
        View in: PubMed
      464. Goadsby PJ, Uddman R, Edvinsson L. Cerebral vasodilatation in the cat involves nitric oxide from parasympathetic nerves. Brain Res. 1996 Jan 22; 707(1):110-8.
        View in: PubMed
      465. Goadsby PJ. Subcutaneous sumatriptan and the migraine aura. Neurology. 1996 Jan; 46(1):286.
        View in: PubMed
      466. Cremer PD, Halmagyi GM, Goadsby PJ. Secondary cluster headache responsive to sumatriptan. J Neurol Neurosurg Psychiatry. 1995 Dec; 59(6):633-4.
        View in: PubMed
      467. Goadsby P. Neuropeptides and migraine--a useful biological marker? Cephalalgia. 1995 Oct; 15(5):333-4.
        View in: PubMed
      468. Goadsby P. What is the physiological role of the trigeminovascular system? Cephalalgia. 1995 Oct; 15(5):333.
        View in: PubMed
      469. Quinn NP, Goadsby PJ, Lees AJ. Hereditary juvenile parkinsonism with pyramidal signs and mental retardation. Eur J Neurol. 1995 Mar; 2(1):23-6.
        View in: PubMed
      470. Edvinsson L, Goadsby PJ. Neuropeptides in the cerebral circulation: relevance to headache. Cephalalgia. 1995; 15(4):272-6.
        View in: PubMed
      471. Humphrey PP, Goadsby PJ. The mode of action of sumatriptan is vascular? A debate. Cephalalgia. 1994 Dec; 14(6):401-10; discussion 393.
        View in: PubMed
      472. Kaube H, Hoskin KL, Goadsby PJ. Acetylsalicylic acid inhibits cerebral cortical vasodilatation caused by superior sagittal sinus stimulation in the cat*. Eur J Neurol. 1994 Nov; 1(2):141-6.
        View in: PubMed
      473. Edvinsson L, Goadsby PJ. Neuropeptides in migraine and cluster headache. Cephalalgia. 1994 Oct; 14(5):320-7.
        View in: PubMed
      474. Goadsby PJ. Nitric oxide is not the sole determinant of hypercapnic or metabolically driven vasodilation in the cerebral circulation. J Auton Nerv Syst. 1994 Sep; 49 Suppl:S67-72.
        View in: PubMed
      475. Jansen-Olesen I, Goadsby PJ, Uddman R, Edvinsson L. Vasoactive intestinal peptide (VIP) like peptides in the cerebral circulation of the cat. J Auton Nerv Syst. 1994 Sep; 49 Suppl:S97-103.
        View in: PubMed
      476. Goadsby PJ, Edvinsson L. Joint 1994 Wolff Award Presentation. Peripheral and central trigeminovascular activation in cat is blocked by the serotonin (5HT)-1D receptor agonist 311C90. Headache. 1994 Jul-Aug; 34(7):394-9.
        View in: PubMed
      477. Goadsby PJ, Hoskin KL. Cerebral blood flow is not coupled to neuronal activity during stimulation of the facial nerve vasodilator system. Brain Res. 1994 Jun 6; 647(2):192-8.
        View in: PubMed
      478. Goadsby PJ, Edvinsson L. Human in vivo evidence for trigeminovascular activation in cluster headache. Neuropeptide changes and effects of acute attacks therapies. Brain. 1994 Jun; 117 ( Pt 3):427-34.
        View in: PubMed
      479. Goadsby PJ, Burke D. Deficits in the function of small and large afferent fibers in confirmed cases of carpal tunnel syndrome. Muscle Nerve. 1994 Jun; 17(6):614-22.
        View in: PubMed
      480. Kaube H, Hoskin KL, Goadsby PJ. Lignocaine and headache: an electrophysiological study in the cat with supporting clinical observations in man. J Neurol. 1994 Jun; 241(7):415-20.
        View in: PubMed
      481. Drummond PD, Finch PM, Edvinsson L, Goadsby PJ. Plasma neuropeptide Y in the symptomatic limb of patients with causalgic pain. Clin Auton Res. 1994 Jun; 4(3):113-6.
        View in: PubMed
      482. Goadsby PJ. Sumatriptan and giant cell arteritis. J Neurol Neurosurg Psychiatry. 1994 May; 57(5):660.
        View in: PubMed
      483. Kaube H, Goadsby PJ. Anti-migraine compounds fail to modulate the propagation of cortical spreading depression in the cat. Eur Neurol. 1994; 34(1):30-5.
        View in: PubMed
      484. Goadsby PJ. The clinical profile of sumatriptan: cluster headache. Eur Neurol. 1994; 34 Suppl 2:35-9.
        View in: PubMed
      485. Kaube H, Keay KA, Hoskin KL, Bandler R, Goadsby PJ. Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat. Brain Res. 1993 Nov 26; 629(1):95-102.
        View in: PubMed
      486. Kaube H, Hoskin KL, Goadsby PJ. Intravenous acetylsalicylic acid inhibits central trigeminal neurons in the dorsal horn of the upper cervical spinal cord in the cat. Headache. 1993 Nov-Dec; 33(10):541-4.
        View in: PubMed
      487. Kaube H, Hoskin KL, Goadsby PJ. Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption. Br J Pharmacol. 1993 Jul; 109(3):788-92.
        View in: PubMed
      488. Goadsby PJ, Seylaz J, Mraovitch S. Noncholinergic, nonadrenergic cortical vasodilatation elicited by thalamic centromedian-parafascicular complex. Am J Physiol. 1993 Jun; 264(6 Pt 2):R1150-6.
        View in: PubMed
      489. Goadsby PJ. Inhibition of calcitonin gene-related peptide by h-CGRP(8-37) antagonizes the cerebral dilator response from nasociliary nerve stimulation in the cat. Neurosci Lett. 1993 Mar 5; 151(1):13-6.
        View in: PubMed
      490. Uddman R, Goadsby PJ, Jansen I, Edvinsson L. PACAP, a VIP-like peptide: immunohistochemical localization and effect upon cat pial arteries and cerebral blood flow. J Cereb Blood Flow Metab. 1993 Mar; 13(2):291-7.
        View in: PubMed
      491. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol. 1993 Jan; 33(1):48-56.
        View in: PubMed
      492. Goadsby PJ, Edvinsson L. Examination of the involvement of neuropeptide Y (NPY) in cerebral autoregulation using the novel NPY antagonist PP56. Neuropeptides. 1993 Jan; 24(1):27-33.
        View in: PubMed
      493. Goadsby PJ, Kaube H, Hoskin KL. Nitric oxide synthesis couples cerebral blood flow and metabolism. Brain Res. 1992 Nov 6; 595(1):167-70.
        View in: PubMed
      494. Goadsby PJ. The oligemic phase of cortical spreading depression is not blocked by tirilazad mesylate (U-74006F). Brain Res. 1992 Aug 14; 588(1):140-3.
        View in: PubMed
      495. Mossman SS, Goadsby PJ. Cocaine abuse simulating the aura of migraine. J Neurol Neurosurg Psychiatry. 1992 Jul; 55(7):628.
        View in: PubMed
      496. Kaube H, Hoskin KL, Goadsby PJ. Activation of the trigeminovascular system by mechanical distension of the superior sagittal sinus in the cat. Cephalalgia. 1992 Jun; 12(3):133-6.
        View in: PubMed
      497. Mraovitch S, Calando Y, Goadsby PJ, Seylaz J. Subcortical cerebral blood flow and metabolic changes elicited by cortical spreading depression in rat. Cephalalgia. 1992 Jun; 12(3):137-41; discussion 127.
        View in: PubMed
      498. Goadsby PJ, Edvinsson L, Ekman R. Cutaneous sensory stimulation leading to facial flushing and release of calcitonin gene-related peptide. Cephalalgia. 1992 Feb; 12(1):53-6.
        View in: PubMed
      499. Jauslin P, Goadsby PJ, Lance JW. The hospital management of severe migrainous headache. Headache. 1991 Nov; 31(10):658-60.
        View in: PubMed
      500. Goadsby PJ, Lollin Y, Kocen RS. Pseudopseudohypoparathyroidism and spinal cord compression. J Neurol Neurosurg Psychiatry. 1991 Oct; 54(10):929-31.
        View in: PubMed
      501. Goadsby PJ, Zagami AS, Donnan GA, Symington G, Anthony M, Bladin PF, Lance JW. Oral sumatriptan in acute migraine. Lancet. 1991 Sep 28; 338(8770):782-3.
        View in: PubMed
      502. Goadsby PJ, Zagami AS, Lambert GA. Neural processing of craniovascular pain: a synthesis of the central structures involved in migraine. Headache. 1991 Jun; 31(6):365-71.
        View in: PubMed
      503. Goadsby PJ, Zagami AS. Stimulation of the superior sagittal sinus increases metabolic activity and blood flow in certain regions of the brainstem and upper cervical spinal cord of the cat. Brain. 1991 Apr; 114 ( Pt 2):1001-11.
        View in: PubMed
      504. Goadsby PJ. Characteristics of facial nerve-elicited cerebral vasodilatation determined using laser Doppler flowmetry. Am J Physiol. 1991 Jan; 260(1 Pt 2):R255-62.
        View in: PubMed
      505. Goadsby PJ, Gundlach AL. Localization of 3H-dihydroergotamine-binding sites in the cat central nervous system: relevance to migraine. Ann Neurol. 1991 Jan; 29(1):91-4.
        View in: PubMed
      506. Edvinsson L, Goadsby PJ. Extracerebral manifestations in migraine. A peptidergic involvement? J Intern Med. 1990 Oct; 228(4):299-304.
        View in: PubMed
      507. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990 Aug; 28(2):183-7.
        View in: PubMed
      508. Zagami AS, Goadsby PJ, Edvinsson L. Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides. Neuropeptides. 1990 Jun; 16(2):69-75.
        View in: PubMed
      509. Goadsby PJ, Shelley S. High-frequency stimulation of the facial nerve results in local cortical release of vasoactive intestinal polypeptide in the anesthetised cat. Neurosci Lett. 1990 May 4; 112(2-3):282-9.
        View in: PubMed
      510. Goadsby PJ, Lance JW. [Physiopathology of migraine]. Rev Prat. 1990 Feb 11; 40(5):389-93.
        View in: PubMed
      511. Goadsby PJ. Sphenopalatine ganglion stimulation increases regional cerebral blood flow independent of glucose utilization in the cat. Brain Res. 1990 Jan 1; 506(1):145-8.
        View in: PubMed
      512. Goadsby PJ, Lambert GA. Electrical stimulation of the fastigial nucleus increases total cerebral blood flow in the monkey. Neurosci Lett. 1989 Dec 15; 107(1-3):141-4.
        View in: PubMed
      513. Goadsby PJ, Lance JW. Clinicopathological correlation in a case of painful ophthalmoplegia: Tolosa-Hunt syndrome. J Neurol Neurosurg Psychiatry. 1989 Nov; 52(11):1290-3.
        View in: PubMed
      514. Goadsby PJ. Effect of stimulation of facial nerve on regional cerebral blood flow and glucose utilization in cats. Am J Physiol. 1989 Sep; 257(3 Pt 2):R517-21.
        View in: PubMed
      515. Goadsby PJ, Duckworth JW. Low frequency stimulation of the locus coeruleus reduces regional cerebral blood flow in the spinalized cat. Brain Res. 1989 Jan 2; 476(1):71-7.
        View in: PubMed
      516. Lance JW, Lambert GA, Goadsby PJ, Zagami AS. 5-Hydroxytryptamine and its putative aetiological involvement in migraine. Cephalalgia. 1989; 9 Suppl 9:7-13.
        View in: PubMed
      517. Lambert GA, Goadsby PJ, Zagami AS, Duckworth JW. Comparative effects of stimulation of the trigeminal ganglion and the superior sagittal sinus on cerebral blood flow and evoked potentials in the cat. Brain Res. 1988 Jun 21; 453(1-2):143-9.
        View in: PubMed
      518. Goadsby PJ, Edvinsson L, Haber PS. Vasoactive peptides and the carcinoid syndrome. Ann Intern Med. 1988 Jun; 108(6):904.
        View in: PubMed
      519. Goadsby PJ, Edvinsson L, Ekman R. Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol. 1988 Feb; 23(2):193-6.
        View in: PubMed
      520. Goadsby PJ, Duckworth JW. Effect of stimulation of trigeminal ganglion on regional cerebral blood flow in cats. Am J Physiol. 1987 Aug; 253(2 Pt 2):R270-4.
        View in: PubMed
      521. Goadsby PJ, Lambert GA, Lance JW. Stimulation of the trigeminal ganglion increases flow in the extracerebral but not the cerebral circulation of the monkey. Brain Res. 1986 Aug 27; 381(1):63-7.
        View in: PubMed
      522. Goadsby PJ, MacDonald GJ. Extracranial vasodilation mediated by vasoactive intestinal polypeptide (VIP). Brain Res. 1985 Mar 11; 329(1-2):285-8.
        View in: PubMed
      523. Piper RD, Goadsby PJ. Pressor response to electrical and chemical stimulation of nucleus raphe dorsalis in the cat. Stroke. 1985 Mar-Apr; 16(2):307-12.
        View in: PubMed
      524. Goadsby PJ. Brainstem activation of the adrenal medulla in the cat. Brain Res. 1985 Feb 18; 327(1-2):241-8.
        View in: PubMed
      525. Goadsby PJ, Lambert GA, Lance JW. The mechanism of cerebrovascular vasoconstriction in response to locus coeruleus stimulation. Brain Res. 1985 Feb 11; 326(2):213-7.
        View in: PubMed
      526. Goadsby PJ, Piper RD, Lambert GA, Lance JW. Effect of stimulation of nucleus raphe dorsalis on carotid blood flow. II. The cat. Am J Physiol. 1985 Feb; 248(2 Pt 2):R263-9.
        View in: PubMed
      527. Goadsby PJ, Macdonald GJ. The effect of infusion of various peptide antisera on vasodilatation in the cat common carotid vascular territory. Clin Exp Neurol. 1985; 21:115-21.
        View in: PubMed
      528. Lambert GA, Bogduk N, Goadsby PJ, Duckworth JW, Lance JW. Decreased carotid arterial resistance in cats in response to trigeminal stimulation. J Neurosurg. 1984 Aug; 61(2):307-15.
        View in: PubMed
      529. Goadsby PJ, Lambert GA, Lance JW. The peripheral pathway for extracranial vasodilatation in the cat. J Auton Nerv Syst. 1984 Apr; 10(2):145-55.
        View in: PubMed
      530. Goadsby PJ, Lambert GA, Lance JW. Dilatation in the carotid vascular territory of the cat in response to activation of cell bodies in the locus coeruleus. Clin Exp Neurol. 1984; 20:63-72.
        View in: PubMed
      531. Goadsby PJ, Lambert GA, Lance JW. Effects of locus coeruleus stimulation on carotid vascular resistance in the cat. Brain Res. 1983 Nov 14; 278(1-2):175-83.
        View in: PubMed
      532. Lance JW, Lambert GA, Goadsby PJ, Duckworth JW. Brainstem influences on the cephalic circulation: experimental data from cat and monkey of relevance to the mechanism of migraine. Headache. 1983 Nov; 23(6):258-65.
        View in: PubMed
      533. Goadsby PJ, Lambert GA, Lance JW. Differential effects on the internal and external carotid circulation of the monkey evoked by locus coeruleus stimulation. Brain Res. 1982 Oct 14; 249(2):247-54.
        View in: PubMed
      Peter's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Back to TOP